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Diagnostic reference levels (DRLs) are pre-determined dose levels employed for pa-
tient dose management in diagnostic radiology. Cone-beam computed tomography
(CBCT) has gained significant popularity in the imaging of the head and neck region
eliciting the need for DRLs for CBCT examinations.
The main objective of the study was to collect dose data for the establishment of
indication-based national DRLs for CBCT examinations of the head and neck region
in Finland as well as to form proposals for the prospective DRLs. In addition,
examination frequencies, the use of optimised imaging parameters and the effect of
manufacturer and model of the CBCT device on dose were studied.
The study was conducted as a nation-wide dose survey among the Finnish facilities
conducting CBCT examinations of the head and neck region. The response rate was
56% in terms of registered devices and 57% in terms of listed places of use.
DRL proposals were made for seven indications. The values for the proposals were
derived from the 75th percentile values of the indication-specific dose distributions.
Very wide dose ranges were observed within all seven indications. The most common
indication was pre-surgical imaging of implant treatments. A significant portion of
the respondents had used default factory settings instead of optimising the imaging
parameters. No particular manufacturer or device model stood out as producing
exceptionally high or low doses regardless of the user. The Finnish DRLs for CBCT
examinations will be issued based on the results of this study.
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Vertailutasot ovat ennalta määrättyjä annostasoja, joita käytetään diagnostisessa ra-
diologiassa potilasannosten hallintaan. Kartiokeilatietokonetomografia (KKTT) on
saavuttanut merkittävän suosion pään ja kaulan alueen kuvantamisessa aikaansaaden
tarpeen vertailutasoille KKTT-tutkimuksissa.
Tutkimuksen päätavoitteena oli kerätä annosdataa kansallisten indikaatiopohjais-
ten vertailutasojen muodostamiseksi pään ja kaulan alueen KKTT-tutkimuksille
Suomessa sekä tehdä ehdotukset tuleville vertailutasoille. Lisäksi selvitettiin tutkimus-
määriä, optimoitujen kuvausparametrien käyttöä sekä KKTT-laitteen valmistajan
ja mallin vaikutusta annokseen.
Tutkimus toteutettiin valtakunnallisena annoskyselynä suomalaisille käyttöpaikoille,
joissa tehdään pään ja kaulan alueen KKTT-tutkimuksia. Vastausprosentti oli 56
% rekisteröityjen laitteiden ja 57 % listattujen käyttöpaikkojen suhteen.
Vertailutasoehdotukset tehtiin seitsemälle indikaatiolle. Ehdotusten arvot johdettiin
indikaatiokohtaisten annosjakaumien 75. persentiilejä vastaavista arvoista. Kaikissa
seitsemässä indikaatiossa annosten vaihteluväli oli todella laaja. Yleisin indikaatio
oli implanttihoitojen preoperatiivinen kuvantaminen. Huomattava osa vastaajista
oli käyttänyt tehtaalla esiohjelmoituja arvoja kuvausparametrien optimoinnin sijaan.
Mikään valmistaja tai laitemalli ei erottunut muista tuottamalla poikkeuksellisen
korkeita tai matalia annoksia käyttäjästä riippumatta. Suomalaiset vertailutasot
KKTT-tutkimuksille julkaistaan tämän tutkimuksen tulosten perusteella.
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11. INTRODUCTION
Radiographic examinations have an essential role in today’s medicine as an impor-
tant part of diagnostics, treatment planning and follow-up on patients [25, p. 9].
Computed tomography (CT) has revolutionised medical radiographic imaging by
enabling three-dimensional (3D) visualisation of structures that previously could
only be depicted in two dimensions (2D) [5]. However, the application of CT to
dental imaging has been strongly hampered by its high dose compared to conven-
tional two-dimensional (2D) methods, large physical size and high costs. Relatively
recently, the afore-mentioned issues were solved by the adoption of cone-beam com-
puted tomography (CBCT) to dental imaging. CBCT is a radiographic imaging
modality that is capable of providing 3D images with a lower dose and cost than
conventional CT. Moreover, for the physical size of CBCT units is small compared
to CT devices, allowing CBCT units to be placed in dental offices. [101] Currently,
CBCT is highly popular in the imaging of the head and neck and also has various
applications outside the traditional dental applications [15; 26, pp. 45–88; 30; 60;
106].
Despite the indisputable benefits of radiographic imaging in medicine, each radio-
graphic examination should be carefully considered because the employment of ion-
ising radiation always entails a risk of detrimental effects to the patient. The po-
tential adverse consequences caused by radiation comprise two types: deterministic
and stochastic effects. Deterministic effects are tissue reactions that occur above a
certain dose threshold. [98, pp. 37–38] When the threshold is exceeded, the occur-
rence of the effects is certain and the severity of the effects is dose-dependent [66, p.
46]. Deterministic effects encompass reactions and conditions, such as erythema,
cataract, infertility and foetal abnormalities [66, pp. 44, 46; 98, pp. 37–38]. Stochas-
tic effects include cancer and heritable effects. In contrast to deterministic effects,
stochastic effects take place without a threshold. Thus, the risk of stochastic effects
is ever-present in radiographic imaging, even at very low doses. [98, pp. 37] Dose
does not affect the severity of stochastic effects but the probability of the effects
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increases with dose [66, p. 45].
Deterministic effects are associated with high single radiation doses [66, p. 44] and
are thus not common in diagnostic radiology [98]. For stochastic effects, the total
risk is determined by the cumulative dose of lifetime exposures to ionising radiation.
For an individual, the risk of stochastic effects can be regarded as relatively small
even in the case of relatively high cumulative doses. [66, p. 45] However, stochastic
effects can lead to a significant health risk at population level if the amount of people
exposed is large, even if the individual doses are low [55; 66, p.45]. This is the case
in dental imaging, where the number of radiographic examinations and patients is
vast [55].
To protect patients from the deleterious effects of radiation, radiographic imaging
practices should always be based on the principles of justification and optimisation.
The afore-mentioned principles essentially state that the benefits of the examina-
tion should outweigh the potential detriment caused by the examination as well as
that the dose to the patient should be as low as can be achieved using reasonable
measures and without losing the required diagnostic information [43, pp. 9–16].
To aid dose management and to initiate the process of optimisation, the concepts
of diagnostic reference levels (DRLs) has been introduced. DRLs are pre-defined
dose levels derived from national dose distributions that should not be repeatedly
exceeded under normal circumstances. [43, p. 23–24; 44; 111] The obligation to
apply DRLs to radiographic imaging is laid down in the Finnish and European leg-
islation [19,111]. In Finland, the DRLs for the most common examination types are
issued by the Radiation and Nuclear Safety Authority (STUK) [19].
The study described in the work at hand was triggered by the need to issue DRLs
for CBCT examinations of the head and neck region in Finland. The study suc-
ceeded in collecting the required nationwide dose data for STUK to establish the
Finnish DRLs for CBCT examinations. To further aid the establishment of DRLs,
proposals compliant with international guidelines were formed for the prospective
DRLs. Moreover, the study revealed new and important information concerning
radiation safety practices, such as the prevalence of optimisation, in CBCT imaging
in Finland.
The following two chapters of the thesis present the theoretical background of the
study. Chapter 2 Cone-Beam Computed Tomography introduces CBCT as an imag-
ing technique and compares it with other modalities employed for the imaging of
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the head and neck region. The chapter also examines the imaging parameters of
CBCT scanners as well as their effect on dose and image quality. Furthermore, the
indications for CBCT examinations are discussed. Chapter 3 Radiation Safety ex-
plores the fundamental principles governing the use of ionising radiation for medical
imaging as well as important pieces of Finnish and international legislation regard-
ing radiation safety. The role of STUK is also elucidated. Moreover, the concept of
DRLs is presented and DRLs are considered by looking at their adoptions in Europe
and Finland as well as at their establishment and application. Chapter 4 Materials
and Methods explains how the survey was conducted and how the obtained data was
processed. Chapter 5 Results and Analysis both presents and analyses the results
of the study. Finally, Chapter 6 Conclusions concludes the study and discusses the
importance of the results.
42. CONE-BEAM COMPUTED TOMOGRAPHY
CBCT is a 3D radiographic imaging technology that arrived at dental offices in the
late 1990’s. The first commercial CBCT device designed for dental imaging was the
NewTom DVT 9000, which entered the European market in the year 1999. [5] Since
then the technology has rapidly gained major popularity in dental imaging [67] and
at present, there are various models from several manufacturers available on the
market [64]. Furthermore, the applications of CBCT in the head and neck region
have extended widely beyond the traditional dental indications [15; 26, pp. 45–88;
30; 60; 106]. Despite being a rather recent imaging modality in the imaging of
the head and neck region, the technology was already developed in the early 1980’s
but was originally used for angiography [5], i.e. for the radiographic imaging of
blood vessels [54, p. 34]. The adoption of CBCT into the imaging of the head and
neck region required technical advancements in computer, X-ray tube and detector
technology, which explains the delay between the its invention and adoption [101].
The first three sections of the chapter introduce the basics of CBCT in terms of the
principle of operation, the process of image production and the main components
of the imaging system. Thereafter, the imaging parameters of CBCT devices are
explored and their effect on dose and image quality are studied. Furthermore, the
adjustability of the parameters is discussed. The chapter also compares CBCT to
other radiographic modalities applied to diagnostic imaging of the head and neck
region. Lastly, the recommended indications for CBCT examinations are examined.
2.1 Principle
At its most fundamental level, the imaging system of a CBCT unit comprises an
X-ray tube and a detector that rotate around the head of the patient [101]. As
in other imaging modalities employing X-rays, the X-ray tube produces a beam of
radiation that is directed at the patient and the radiation that traverses the patient
is registered by the detector [28]. The key to CBCT technology is the shape of the
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Figure 2.1 The principle of cone-beam computed tomography. Reproduced with permission
of British Institute of Radiology from [67] in the format Republish in a thesis via Copyright
Clearance Center.
X-ray beam, which is that of a cone or a pyramid [101]. Owing to the geometry of
the beam, the entire area desired to be imaged, i.e. the region of interest (ROI),
can be enclosed within the beam. [28, 101] From the foregoing it also follows that
only a 180- to 360 -degree rotation of the tube-detector pair is sufficient to capture
the data required for the reconstruction of final the image [67]. The volume of the
object scanned by the X-ray beam is denoted by the term field of view (FOV) [63, p.
148]. The size of the FOV should be as close to that of the ROI as possible to avoid
unnecessary radiation exposure to the patient [98, p. 89].
The above-discussed principle of CBCT imaging is depicted in Figure 2.1. The figure
shows the X-ray tube and the detector as well as their position on the opposite sides
of the patient. The rotation of the tube-detector pair about a vertical axis around
the head of the patient is demonstrated by the arrow. Figure 2.1 also illuminates
the beam geometry examined in the previous paragraph. The volume referred to as
scanned volume in the figure, depicts the FOV.
2.2 Image Production and Display
As the tube-detector pair rotates around the patient, a series of sequential 2D im-
ages is captured by the detector [101]. The series consists of 128–1024 images, which
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are referred to as basis images [51]. The series of basis images is also called the pro-
jection or raw data [67]. After acquiring the basis images, the images are processed
by correcting inhomogeneities originating from non-idealities in the operation of the
detector, such as pixel defects. The final image is generated from the corrected raw
data by applying a reconstruction algorithm to each of the basis images and then
combining the reconstructed images into a single 3D volume. A popular reconstruc-
tion algorithm used in CBCT is the Feldkamp-Kress-Davis algorithm that employs
filtered backprojection. [67, 101] The 3D volume is comprised of voxels, i.e. small
volume elements that can be considered the 3D equivalent of 2D pixels [28]. In
CBCT, the voxels of the resulting 3D volumes are isotropic, meaning that the voxel
dimensions are equal in all directions [51].
The resulting CBCT images can be viewed in numerous formats, including 3D visu-
alisations, 2D images in different planes as well as images simulating those obtained
from conventional 2D dental radiography [67]. In 2D, CBCT images can be visu-
alised in the three anatomical orthogonal planes (axial, coronal and sagittal) [1]. It
is also possible to display images in non-orthogonal, such as oblique, planes [67].
Examples of the simulated images include visualisations mimicking pantomographic
and cephalometric images [5, 12]. Pantomographic and cephalometric imaging are
discussed in Section 2.5 Comparison to Other Imaging Modalities.
2.3 Components of the Imaging System
As described above, CBCT units include an X-ray tube and a detector that revolve
around the patient’s head. The tube-detector pair is attached to a gantry. [101] In
the case of most CBCT units designed for the imaging of the head and neck, the
patient is in a standing position. In many of the afore-mentioned units, the height
of the tube-detector pair can be adjusted making it possible to image patients in a
wheelchair. Some CBCT systems include a built-in patient chair and the patient is
imaged in a seated position. [51] Examples of the afore-mentioned types of CBCT
units are presented in Figure 2.2. Moreover, there are also CBCT systems, in which
the patient is supine, but such systems are uncommon among those dedicated to
the imaging of the head and neck [51].
The X-ray tubes used in CBCT operate at a rather low power [61] with tube peak
voltages (kVp) and currents in the range of 40–120 kVp and 1–32 milliamperes (mA),
respectively [51]. The X-ray sources of CBCT devices generate X-rays in either a
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(a) An example of a CBCT unit,
in which the patient is imaged in
a standing position [73].
(b) An example of a CBCT unit with
a built-in patient chair [49].
Figure 2.2 Examples of CBCT units designed for the imaging of the head and neck region.
pulsed or continuous fashion. In the case of continuous X-ray production, X-rays
are generated ceaselessly during the whole scanning time. [67, 101] However, the
detector is not capable of continuous detection because time is also required to
collect and forward the detected signal [1]. Moreover, the detector needs to move
to the position, from which the subsequent basis image is taken [100]. Thus, when
X-rays are generated continuously, the patient is exposed to radiation that does
not contribute to image production [101]. Frame rate is a measure that describes
the number of images the detector can produce per second [100]. In pulsed X-ray
production, the generation of X-rays is intermittent and synchronised with the frame
rate of the detector so that exposures are not made during the time the detector is
unavailable for detection [1,67,101]. Consequently, the dose to the patient is reduced
compared to continuous X-ray production [101].
Important components of the CBCT imaging system associated with the X-ray tube
are the collimators. Collimators refer to lead-alloy shields that allow the beam to
be focused onto a limited area, enabling the FOV to be smaller than the entire head
of the patient. The collimators form openings that direct the beam. Most CBCT
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units have more than one pre-defined opening size and thereby, provide more than
one FOV size. [67]
CBCT systems employ area detectors of two alternative types: detectors consisting
of image intensifiers (II) combined with charge-coupled devices (CCDs) and flat
panel detectors (FPDs) containing arrays of hydrogenated amorphous silicon thin-
film transistors (TFTs) or complementary metal oxide semiconductors (CMOSs) [5].
II/CCD detectors are found in older CBCT units, whereas FPDs are used in the
majority of modern CBCT devices [51]. The basic principle of operation is the same
for both FPD detector types. The detectors include a scintillator material that
converts the detected X-rays to visible light photons. The light photons, in turn,
are converted into electrical charge by photodiodes incorporated into the detectors.
The produced charge is then collected and read out to produce the output signal of
the detectors. [5]
CBCT units typically employ a separate computer for image acquisition, from which
the data is sent to another computer to be processed. The reconstruction and display
of images can be performed on a personal computer (PC). Thus, no specialised
workstations for image processing are needed. [101]
2.4 Imaging Parameters
The purpose of diagnostic radiographic imaging is to gain information to answer the
clinical question, for which the imaging examination has been prescribed. In acting
to achieve the foregoing objective, the following two aspects should be considered:
the quality of the images obtained through the imaging examination as well as
the radiation dose received by the patient. The quality of the resulting images
should be such that sufficient diagnostic information is provided. However, at the
same time, the ALARA principle should be abided by. [14] ALARA stands for ”as
low as reasonably achievable” and accordingly, the principle states that the patient
radiation dose should be as low as can be achieved using reasonable measures and
without the required diagnostic information being lost [111]. The ALARA principle
is addressed in more detail in the next chapter. Both the patient dose and image
quality are influenced by the choice of imaging parameters, such as the FOV size and
tube current [67]. The main imaging parameters and their effect on dose and image
quality are summarised in Table 2.1 and further discussed in the first subsection.
The second subsection explores the possibilities of the user to adjust and optimise
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the parameters.
2.4.1 Effect on Dose and Image Quality
Image quality can be regarded as an entity composed of several components, some of
which are inter-related. The afore-mentioned components include spatial resolution,
contrast, noise and artefacts. Spatial resolution indicates the ability to discern
small details from each other. Contrast describes how well distinction between
regions of different density can be made. Noise and artefacts, in turn, are undesired
components introduced into the image. Noise refers to unwanted random variation
in the image signal, whereas artefacts are non-random elements seen in the image
that do not have a counterpart in the actual object that is imaged. An important
source of artefacts in CBCT is scattered radiation from the patient that reaches the
detector and thereby, contributes erroneously to the detected signal. Due to their
inter-relatedness, the afore-mentioned components should be considered together
when assessing image quality. In radiological imaging, image quality is influenced
by the following imaging parameters: FOV size, tube current and voltage as well as
voxel size. [67]
Table 2.1 The effect of imaging parameters on patient dose and the components of image
quality. Adapted from [67]. ↑ denotes an increase and ↓ a decrease in an imaging parameter
or in an effect on the components of image quality.
Imaging Parameter
Spatial
resolu-
tion
Contrast Noise Artefacts PatientDose
FOV size ↑ - ↓ ↑ ↑ ↑
Tube current ↑ - - ↓ - ↑
Tube voltage ↑ - ↓ ↓ - ↑
Voxel size ↓ ↑ - ↑ - -
By increasing the tube current, noise in the resulting image can be reduced. How-
ever, the magnitude of the tube current is directly proportional to the number of
X-ray photons that are produced in the X-ray tube. Thus, the tube current has a
direct effect on radiation dose, and the noise reduction achieved by increasing the
tube current comes with the cost of an increased patient dose. Noise reduction can
also be accomplished by increasing the tube voltage. However, at the same time, an
increase in tube voltage results in decreased contrast. Furthermore, as in the case
of the tube current, increasing the tube voltage leads to a higher patient dose. [67]
2.4. Imaging Parameters 10
In contrast to the parameters discussed above, increasing the FOV size does not
provide benefits in terms of image quality. On the contrary, the employment of large
FOV sizes results in decreased contrast as well as added noise and more artefacts due
to an increase in scattered radiation captured by the detector. Additionally, large
FOVs entail high patient doses. It has to be noted though, that the use of small
FOV sizes also causes the formation of certain types of artefacts. This is because
in the case of small FOVs, a large portion of the patient’s head is left outside the
FOV and the mass corresponding to that portion interferes with the generation of
the projection data, from which the eventual image is reconstructed. However, in
many cases the foregoing artefacts can be regarded as being of only minor practical
importance in CBCT imaging. [67]
The effect of voxel size on image quality is that spatial resolution is improved when
the voxel size is decreased. However, the reduction in voxel size simultaneously
causes the image to become noisier. The voxel size per se does not influence the dose.
Yet, in some CBCT units, the adjustment of voxel size is incorporated into resolution
settings or protocols, which alter the tube current according to the voxel size. Such
resolution settings or protocols employ higher tube currents to compensate for the
added noise caused by voxel size reduction. As a consequence of the increase in tube
current, the patient dose becomes higher. [67]
2.4.2 Adjustability and Optimisation
The technical specifications, including the imaging parameters, of 45 different dental
CBCT units were recently reviewed by Kiljunen et al. [51]. According to the review,
the adjustability of imaging parameters varies significantly between different CBCT
models. There are differences in which parameters and to which degree they can be
adjusted by the user. [51] Thus, the possibilities of the user to influence the imaging
parameters is highly dependent on the CBCT device at hand.
The user can modify the tube current almost without exception in all CBCT devices
reviewed by Kiljunen et al. However, the range of available adjustment offered by
some units is only a few milliamperes, whereas in some devices the range covers over
30 mA. The review shows that there are several CBCT units on the market that
have a fixed tube voltage. An adjustable tube voltage is, nevertheless, more common
and a typical range of adjustment is 60–90 kVp. In most of the reviewed scanners
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the user can choose between pre-defined FOV size options. The number of the pre-
defined FOV sizes is highly variable between different CBCT models, ranging from
only one option up to 20 options. The FOV sizes extend from 4 cm x 4 cm/5 cm x
5 cm (diameter x height) to 23 cm x 26 cm. The sizes within the foregoing range do
not, however, follow any standard but every manufacturer has their own sizes. The
exact sizes also differ between the models of the same manufacturer. The possibility
to freely adjust the dimensions of the FOV within certain limits is rare, with such a
feature being available in only one of the reviewed CBCT devices. Voxel size options
are also provided in most CBCT units. [51]
Most CBCT units also have pre-defined protocols or programmes that provide de-
fault values for imaging parameters according to the imaging task and/or the size
of the patient entered by the user [64, 68]. Studies have reported, however, that
sufficient image quality is attainable with lower tube currents and/or voltages than
those of the default settings [18,31,52,68,108]. Thus, in conformity with the ALARA
principle, users should not settle for the default values provided by the CBCT de-
vices but optimise the values to reduce the patient dose within the limits of adequate
image quality required by the clinical question.
With regard to optimising imaging parameters to achieve the best compromise be-
tween patient dose and image quality, the FOV size can be considered the most
straightforward parameter. That is because the use of an unnecessarily large FOV
size not only increases the dose to the patient but also degrades image quality, as
discussed earlier in the section. The optimisation of the tube current and tube volt-
age is more complicated because an increase in the foregoing parameters results in
better image quality in terms of less noise but in higher patient dose. [67] However,
the effect of tube current reduction is more prominent on dose than on image qual-
ity. The foregoing is explicable by the inverse square law for dose and noise, which
states that dose is inversely related to the square of noise. [51] Thus, the adjustment
of tube current is an important means of lowering patient dose without causing un-
acceptable deterioration of image quality. The reduction of tube voltage has been
found to degrade image quality more than the lowering of tube current [69]. Efforts
should, however, be made to adjust the tube voltage according to the size of the
patient, especially when imaging children [51].
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2.5 Comparison to Other Imaging Modalities
Besides CBCT, other radiographic imaging modalities applied to the examinations
of the head and neck region include intra-oral radiography, panoramic tomography,
cephalometric imaging and multi-slice computed tomography (MSCT) [12]. Addi-
tionally, plain 2D radiography is used in the head and neck region but only to a minor
extent [17]. Intra-oral radiography and panoramic tomography comprise the tradi-
tional 2D radiographic methods in dental imaging [26, p. 72]. They are the main
and in many cases, the only modalities needed for dental imaging purposes [107].
2.5.1 Two-Dimensional Radiography
Intra-oral radiography refers to an imaging technique, in which the X-ray tube is out-
side the patient but the image receptor is placed inside the patient’s mouth [109, p.
50]. The technique incorporates the possibility of obtaining three projection types.
The projections differ from each other by depicting different parts of the tooth and
different amounts of bone around the tooth. [72, p. 109] Intra-oral radiography pro-
vides high spatial resolution [12] and can be used for the imaging of a single tooth
or a few adjacent teeth [79; 109, p. 50]. In addition to high spatial resolution, the
advantages of intra-oral radiography encompass low dose, low cost and the simplic-
ity of the examinations. However, a significant limitation to the use of intra-oral
radiography is that 3D structures are depicted in 2D resulting in superimposition of
structures, which in turn can lead to structures and lesions not being visible in the
images. [62] Furthermore, the 2D representation of 3D structures can cause misin-
terpretations on the dimensions of lesions. For example, bone defects may appear
smaller in the images than they are in reality. [7, 62]
Panoramic tomography is an imaging modality that has been on the market since the
1960’s and was developed by a Finnish professor, Yrjö Paatero. Similar to CBCT,
also panoramic tomography employs an X-ray tube and detector that are located on
opposite sides of the patient’s head and that rotate around the head about a vertical
axis of rotation. In contrast to CBCT, in panoramic tomography, the beam is narrow
in the vertical plane and is of the shape of a fan. The movement of the X-ray tube
occurs behind the head of the patient and covers a trajectory slightly longer than
a semicircle. [109, pp. 73–75] Panoramic tomography produces a single 2D image
covering a large area, including the jaws, the teeth, the temporomandibular joints
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(TMJ) and maxillary sinuses [107]. TMJ is the joint between the lower jaw bone and
the skull [54, p. 386]. Maxillary sinuses refer to the air-filled cavities located in the
maxillary bone on both sides of the nose [54, pp. 568, 656]. The spatial resolution in
pantomographic images is, however, poorer than in intra-oral radiography [12]. As a
2D modality, also panoramic tomography suffers from superimposition of structures,
with overlap of oral structures and the cervical spine being projected onto the images.
Due to reasons arising from technique, only one image layer or plane can be brought
into focus in pantomographic imaging. At the centre of the afore-mentioned layer
structures are sharply depicted in the resulting image, whereas the visualisation
of objects located elsewhere is hampered by blurring and distortion. [107] Thus,
panoramic tomography is applicable to imaging tasks, in which a broad view is
desired but the requirements for resolution or anatomical detail are not high [56, p.
175]. Besides covering an extensive area, the advantages of panoramic tomography
include low dose and convenience of performing the examinations due to their short
duration and them being extraoral [56, p. 175; 107].
Panoramic imaging devices can also be fitted with an additional piece of equip-
ment, a cephalostat, to enable cephalometric imaging [79]. Cephalometric imaging
is concerned with the assessment of relations between specific points in the skull
and is utilised in orthodontics. The cephalostat is used for positioning the patient’s
head in order to conduct the skull assessment in a standardised manner. Besides
panoramic units fitted with cephalostats, also separate X-ray devices dedicated to
cephalometric imaging only are available. [113, pp. 161–162, 166–168]
Plain 2D radiography has been superseded by other imaging modalities for most
indications in the head and neck region [17]. However, plain radiography still has
a role in the imaging of paranasal sinuses in Finland [114]. Paranasal sinuses refer
to the normally air-filled cavities located in the bone surrounding the nasal cavity,
including the previously mentioned maxillary sinuses. [54, pp. 568, 656]. Accord-
ing to the current Finnish care guidelines regarding inflammations of the paranasal
sinuses, plain radiography often provides sufficient information if radiographic imag-
ing is required for recurrent acute inflammations [114]. In favour of using plain 2D
radiography is also that the examinations are easy and rapid to perform. Moreover,
the costs and dose are relatively low. [17] However, the employment of plain radio-
graphy for the imaging of sinuses has also received heavy criticism, stating, among
others, that it has a low diagnostic value due to projection effects in the images [17]
as well as that it produces a significant amount of false positive and negative results
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when applied to the diagnostics of sinus inflammations [17,29].
2.5.2 Three-Dimensional Imaging Modalities
Both CBCT and conventional CT produce 3D images and thereby, provide a solution
to the problems inherent to 2D radiography that result from 3D structures being
depicted in 2D. However, the technique underlying image production as well as the
components of the imaging systems differ between the afore-mentioned modalities.
The differences result in the physical size, cost, dose and image quality of CBCT
and conventional CT devices being distinct from each other. [5]
The principle of conventional CT imaging is shown in Figure 2.3. As seen in the
figure, a fundamental difference between CBCT and CT is the shape of the X-ray
beam. In contrast to the cone- or pyramid-shaped beam employed in CBCT, the
beam in CT is the shape of a fan. [101] Similar to CBCT, the X-ray source rotates
around the patient with detectors on the opposite side of the patient. However,
unlike in most CBCT devices, the patient is supine on a patient table and the
rotation of the X-ray source and detectors takes place about a horizontal axis. [5]
Due to the imaging system incorporating a patient table, the footprint of the device
is larger than that of a CBCT device [5], in most of which the patient is imaged in
a standing or a seated position [51].
Following from the shape of the beam in CT, the beam only covers a slice of the
patient instead of the entire ROI, like in CBCT. Consequently, the patient has to
be imaged slice by slice. [101] The foregoing requires several rotations of the X-ray
source as well as translational motion of the patient table. In former generations
of CT devices, only one image slice was captured during a rotation of the X-ray
source, whereas the multi-slice technology employed by the modern CT devices, i.e.
MSCT systems, enables multiple slices to be acquired per rotation. Furthermore,
because the 3D image volume in conventional CT is assembled by stacking the afore-
mentioned axial image slices, the FOV cannot be restricted to a small area within
the patient’s head like in CBCT. [5]
Due to the different beam geometry, also the detector types employed by CBCT
and MSCT differ from each other. Instead of area detectors used in CBCT units,
CT systems incorporate arrays of small detectors arranged in an arc configuration.
In the multi-slice technology, there are several rows of detector arrays adjacent to
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Figure 2.3 The principle of computed tomography. Reproduced with permission from [13],
Copyright Massachusetts Medical Society.
each other. The detectors are either xenon gas detectors or detectors composed of
a scintillator medium and a photon detector. [5]
Besides the detector types, also the requirements for tube power and image process-
ing software are dissimilar between CBCT and MSCT. The X-ray tubes of MSCT
units typically operate at a higher power than those of CBCT systems, with es-
pecially the tube currents being higher than those used in CBCT. MSCT requires
more of the software used for image processing than CBCT. Thus, unlike in CBCT,
a PC is not sufficient for image reconstruction in MSCT and accordingly, a special
workstation for image processing is a part of the MSCT imaging system. [5]
It is possible to assess both bone and soft tissues in 3D using MSCT and thus, in
that respect MSCT is applicable to the evaluation of almost all pathologies of the
head and neck region. [12] However, especially in dental imaging, the use of MSCT is
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problematic due to issues concerning dose, cost and availability [101]. The effective
dose of MSCT is substantially higher than that of the conventional 2D radiographic
methods [26, p. 31]. Furthermore, due to the high cost and large physical size of
MSCT devices, the availability of MSCT for dentists is very restricted [101].
The CBCT technology has, however, succeeded in overcoming the above-mentioned
problems regarding CT and dental imaging and thereby, also enabled the use of
3D imaging for dental applications. MSCT systems require a large physical space,
whereas space available in dental office settings is sufficient for CBCT units due
to their smaller footprint. The smaller size and the above-discussed differences
in the technology and components of the imaging system result in CBCT units
being affordable compared to MSCT devices. In effect, the price of a CBCT unit
is approximately 1/4–1/5 that of a MSCT device. Furthermore, in comparison to
MSCT, significant dose reductions can be achieved by using CBCT. [101] However,
the range of effective doses for CBCT is extensive, including effective doses of the
same magnitude as those of MSCT [70]. A key factor influencing the dose of CBCT
is the selection of an appropriate FOV size [98, p. 89]. It is also to be noted that
the effective doses of CBCT are, nevertheless, higher than those of conventional 2D
methods [26, pp. 30–31].
A major limitation to the use of CBCT is its poor contrast resolution, rendering the
modality unsuitable for imaging tasks involving soft tissues. Moreover, the images
produced by CBCT contain more noise than those produced by MSCT. The main
causes for the poor contrast resolution and noise in CBCT are the shape of the beam
causing a significant amount of scatter radiation as well as the lower tube voltages
and currents compared to MSCT. [5] Consequently, when information on soft tissues
is required, the radiographic imaging modality of choice is MSCT in the head and
neck region [5]. The spatial resolution, however, has been stated to be higher in
CBCT than in MSCT [12].
2.6 Applications of Cone-Beam Computed Tomography in
the Head and Neck Region
In literature, an extensive number and variety of applications of CBCT can be
found [15; 26, pp. 45–88; 30; 60; 106]. However, despite having several potential
applications, CBCT is not always the most appropriate imaging or examination
method for those. For example, in dental and maxillofacial imaging, the information
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provided by CBCT may not alter the diagnosis or treatment plan proposed based
on conventional radiography but often entails higher costs and patient dose. [26] To
identify the situations where CBCT offers benefit for both the dentist or physician
and the patient, recommendations and guidelines have been issued [26, 36]. The
section explores the guidelines and recommendations issued on the clinical use of
CBCT as well as the applications of CBCT in the head and neck, with the emphasis
on the indications suggested by evidence-based guidelines.
2.6.1 Guidelines and Recommendations
A recent review by Horner et al. [36] found 11 publications that specifically pertained
to CBCT imaging and contained guidelines or recommendations on the clinical use
of CBCT. Furthermore, an additional 15 publications were identified that also in-
cluded guidelines and recommendations on the clinical employment of CBCT but the
foregoing publications were not specific to CBCT. Out of the afore-mentioned sets
of guidelines, only two were rated as evidence-based by the authors of the review:
those issued by the SEDENTEXCT consortium [102] and the national guidelines for
CBCT of Germany [20].
The guidelines by SEDENTEXCT were issued in 2011 [102]. The afore-mentioned
guidelines were also published in 2012 in the publication ”Radiation Protection No
172” by the European Commission (EC) [26]. The SEDENTEXCT guidelines were
prepared by a multidisciplinary team of experts, including medical physicists, den-
tists and dental radiologists [102]. The current version of the national guidance of
Germany is from the year 2013 [20].
2.6.2 Indications according to SEDENTEXCT Guidelines
In general, according to the SEDENTEXCT guidelines, CBCT is indicated when
the information obtained from conventional radiography is insufficient or is in con-
tradiction with clinical findings. Furthermore, CBCT is a justified alternative for
MSCT when its dose has been demonstrated to be lower and information on soft
tissues is not needed. The foregoing guidelines propose indications for CBCT that
comprise three main categories: the developing dentition, restoring the dentition
and surgical applications. [26]
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The category developing dentition contains indications pertaining to children. The
children’s indications, for which CBCT may be used according to SEDENTEXCT
are the following: the assessment of impacted teeth and potential resorption, i.e.
breakdown of adjacent teeth, associated with the impaction, the evaluation of cleft
palates as well as the planning of management and surgery in complicated orthodon-
tic cases. [26] An impacted tooth is a tooth that has failed to erupt normally [38].
Cleft palate refers to a birth defect, in which the oral development is abnormal re-
sulting in a gap in the roof of the mouth. Cleft palates are corrected surgically. [16]
Orthodontia is concerned with problems related to the teeth and jaw, such as ab-
normal bite, gaps between teeth as well as crooked and misaligned teeth [65].
The category restoring the dentition includes endodontics, periodontal and periapi-
cal diseases as well as dental trauma [26]. Endodontics deals with the inside of the
tooth, i.e. the dental pulp and the root canals of the tooth [3; 54, p. 139]. In
endodontics, possible indications for CBCT include planning of endodontic surgery
as well as the evaluation of root canal morphology and root resorption [26], i.e. the
loss of structures of the tooth root [3]. Periodontal diseases refer to diseases of the
tissues that surround the teeth and to which the teeth are attached [54, p. 547].
Periodontal diseases can cause loss of bone around the teeth, for the assessment
of which CBCT may be useful [2, 26]. Periapical diseases result from an infection
in the dental pulp that spreads through the root canal to affect the areas at the
tip and around the tooth roots [37, 115]. The use of CBCT may be advisable in
situations where symptoms and clinical findings suggest periapical disease but con-
ventional radiography reveals no signs thereof [26]. Regarding dental trauma, the
SEDENTEXCT guidelines mention suspected root fractures as a possible indication
for CBCT [26].
Surgical applications of CBCT proposed by the SEDENTEXCT guidelines encom-
pass pre-surgical imaging for the removal of wisdom teeth as well as for implant
dentistry. Regarding wisdom tooth extraction, the use of CBCT may be appropri-
ate in cases where conventional radiography has shown that the tooth to be removed
is in close vicinity of the mandibular canal. The mandibular canal contains nerves,
which are at risk for damage during surgical extraction if the tooth is closely related
to the canal. In implant dentistry, CBCT may be indicated for obtaining informa-
tion on the amount and quality of bone at the prospective implant site as well as
on the location of other anatomical structures in relation to the implant site prior
to surgery. Other surgical applications suggested by the afore-mentioned guidelines
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include the assessment of jaw bone defects caused by cancer as well as changes and
abnormalities in the bony structures of the TMJ. Additionally, planning of orthog-
nathic surgery is also on the list of surgical applications for CBCT. [26] Orthognathic
surgery deals with the correction of skeletal abnormalities of the lower or upper jaw
bone or both [4].
2.6.3 Other Indications
The SEDENTEXCT guidelines are mainly focused on the dental applications of
CBCT, whereas the previously mentioned national guidelines of Germany are broader
with respect to other indications in the head and neck area [20, 26]. An important
indication for CBCT not included in the SEDENTEXCT guidelines but covered by
the German ones, is the imaging of paranasal sinuses. CBCT has emerged as a
substitute for MSCT in the imaging of paranasal sinuses and its use for the imag-
ing of sinuses has become common [15, 30, 106]. The German guidelines state that
CBCT should be used to detect and differentiate pathologies of the sinuses when
the foregoing is not possible with 2D radiographic methods. Moreover, CBCT may
be indicated for the pre-operative imaging of the sinuses in individual cases, where
surgery involving the sinuses is planned, and there are grounds for the assessment
of the status of the sinuses based on the medical history and clinical situation of the
patient. A suspected inflammation in the sinuses is an example of the latter. [20]
Other indications for CBCT in the head and neck area included in the German
guidelines encompass the following: salivary stones, fractures of the facial bones,
the localisation of foreign bodies as well as the assessment of the upper airways.
According to the guidelines, the use of CBCT may be indicated in individual cases
for the exact localisation of salivary stones but not for the assessment of other
pathologies of the salivary glands. Regarding the fractures of the facial bones,
CBCT can be employed to determine the precise location of the fracture fragments.
However, in case of suspicion that also the brain is affected or that the soft tissues are
damaged, MSCT should be preferred over CBCT. The localisation of foreign bodies
in the mouth, jaw and face area is regarded as a possible indication for CBCT in
the guidelines. Concerning the assessment of the upper airways, the guidelines state
that CBCT imaging may be indicated in special cases, such as with patients with
proven sleep apnoea symptoms. [20]
Besides the above-discussed indications for CBCT found in the SEDENTEXCT and
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the national German guidelines, other applications reported in literature include the
imaging of the cervical spine, the evaluation of the position of inner and middle ear
implants and computer-aided surgical planning [60,106]. Implant treatments are an
example of a branch of dentistry, to which computer-aided surgical planning em-
ploying CBCT has been applied [9,106]. The data obtained through CBCT imaging
can be imported to a surgical planning software, which allows the implant procedure
to be virtually planned and simulated [8]. In addition to producing virtual simu-
lations and models, CBCT data in conjunction with surgical planning programmes
can be utilised to fabricate physical 3D models and surgical guides by rapid proto-
typing [8, 9, 106]. Surgical guides are templates that are used in implant surgery to
assure that the implants are placed in the exact correct location and orientation [97].
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3. RADIATION SAFETY
The core of radiation safety in medical radio-diagnostic imaging is that the benefits of
the examinations exceed the detriment caused to the patient and that the patient is
not exposed to any excessive radiation. To ensure and contribute to radiation safety
in medical imaging, principles, recommendations and pieces of legislation have been
issued. Furthermore, several international, regional and national bodies are involved
in promoting and regulating radiation safety. The chapter examines the fundamental
principles governing radiological protection as well as the national and international
bodies acting in the field. Moreover, the European and Finnish legislation and
requirements regarding the medical use of radiation are explored. Also the concept
of DRLs is introduced and discussed in depth from several viewpoints.
3.1 Radiological Protection
The principles of justification and optimisation are the fundamental principles gov-
erning radiological protection in medical imaging. The principal international body
in the field of protection against ionising radiation is the International Commission
on Radiological Protection (ICRP) [46, p. 6].
3.1.1 International Commission on Radiological Protection
ICRP is a non-profit, non-governmental organisation founded in 1928 to promote ra-
diological protection. ICRP issues recommendations and guidelines aimed at people,
organisations and agencies functioning in the field. The foregoing include advisory
and regulatory agencies responsible for radiation safety, such as national author-
ities. ICRP reaches its audience through the journal Annals of ICRP, which is
published four times a year. [46, pp. 6, 38] In addition to recommendations and
guidelines, the publications by ICRP encompass supplementary information to the
recommendations, reviews on topical issues pertaining to radiation and radiological
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protection, compendiums of reference data and coefficients as well as symposium
proceedings [40].
The recommendations by ICRP are broad in nature and cover radiological protection
at a fundamental level. The role of the other publications, in turn, is to focus on
specific topics and delve deeper into them. The recommendations and guidelines of
ICRP enjoy an eminent status and form the basis for national legislation on radiation
protection globally as well as for the European directives concerning the field. [46, pp.
3, 36–37] In their current form, the recommendations of ICRP have been published
since 1959 [46, p. 3], when the recommendations adopted in 1958 were presented in
Publication 1 [41]. Thereafter, the recommendations have been revised three times.
The latest version of the recommendations dates back to 2007. [46, p. 3]
The approach to radiological protection employed by ICRP relies on three fundamen-
tal principles: justification, optimisation and the application of dose limits [46, p. 1].
Dose limits or constraints are not applied in medical exposures [46, p. 14] and there-
fore, the third principle on the list is not discussed in the study. The next subsection
is dedicated to the exploration of the principles of justification and optimisation.
3.1.2 General Principles
The principle of justification and the principle of optimisation form the basis for
the safe use of radiation in medicine [47, p. 5]. The principle of justification deals
with the balance between the expected benefits entailed by the use of radiation and
the potential deleterious consequences caused by the exposure to radiation. The
principle of optimisation, in turn, is concerned with the radiation dose the patient
is exposed to during a medical examination or procedure. [111]
Medical examinations and procedures that employ ionising radiation, including ra-
diographic imaging, pose the patient at risk of adverse health effects, such as cancer
and radiation damage [47, p. 5]. In many cases, the risk can be considered relatively
low, but it is nevertheless existent. Therefore, imaging using X-rays should never be
performed unnecessarily or as a routine examination. [25, pp. 9, 14–16, 18] However,
on the flip side, radiographic imaging is a fundamental tool in obtaining the correct
diagnosis, in deciding on the most appropriate treatment as well as in following
up on the patients [25, p. 9]. Thus, the employment of radiographic imaging can
provide significant benefits despite the risks and thereby, it neither can, nor should,
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always be avoided [46, p. 41; 47, p. 6]. According to the principle of justification,
the medical use of radiation is justified, when the expected benefits thereof to the
patient and the society outweigh the potential harm caused to the patient [111].
In assessing the justification of the examination, the following aspects should be
considered: the purpose, the aims and the information value of the examination,
information on the patient obtained from medical records and by means of clinical
examination as well as alternative examination options available [19; 25, p. 18; 47,
p. 7; 111]. In essence, the examination should be appropriate for its purpose and
the patient suited for the examination [47, p. 7]. Unjustified examinations must not
be conducted [43, p. 9].
The premise of the principle of optimisation is to avoid unnecessary radiation expo-
sure to the patient being examined [19]. The foregoing involves the application of
the ALARA principle. The ALARA principle implies that the patient dose should
be the lowest that can be attained using reasonable measures, on the condition that
the needed diagnostic information is acquired. In this context, the term ”reasonable”
refers to considering financial and social factors involved in the measures taken to
protect the patient from radiation. In other words, dose reduction should not be
conducted at the cost of unduly high expenses or disproportionate deterioration of
image quality, nor should it render performing the examination too complex. [43, pp.
13–16] Thus, complying with the principle of optimisation does not necessarily equal
minimising the dose [46, p. 92]. Instead, optimisation is a weighing process between
the exposure, the resulting image quality and the investment of resources, where the
most beneficial combination of the afore-mentioned factors is sought [43, p. 14]
Optimisation is rated as the most effective means of radiological protection by ICRP
in Publication 73 that is concentrated on safety in medical exposures [43, p. 13].
Also the latest recommendations of ICRP underline the role of optimisation in ra-
diation safety [46, p. 14, 44]. Optimisation should cover the entire examination
process: both the equipment and the courses of action, i.e the methods and pro-
tocols employed. In medical exposures, the significance of the courses of action is
pronounced since they directly affect the patient. [43, p. 13] In conjunction with
optimisation in medical exposures, ICRP mentions DRLs a method for controlling
the dose received by the patient. [43, p. 15; 46, p. 128] DRLs are examined in depth
in the last section of the chapter.
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3.2 Regulation
From the European and Finnish perspective, important pieces of legislation concern-
ing radiation safety in medical imaging include the Basic Safety Standards (BSS)
Directive and its predecessor the Medical Exposure Directive (MED) as well as in
the Finnish legislation, the Radiation Act and the Decree of the Ministry of Social
Affairs and Health (MSAH) on the medical use of radiation. In Finland, the regu-
latory body in the field of radiation safety is STUK. STUK is also responsible for
issuing DRLs for the most common examination types in Finland.
3.2.1 Legislation
The general principles explored above are also legally binding in the European Union
(EU) since they are laid down in the Council Directive 2013/59/Euratom, also re-
ferred to as the BSS Directive [112], that is concerned with protection against ion-
ising radiation. The directive also requires the establishment and use of DRLs in
radiodiagnostic examinations. As a member of the EU, Finland must transfer the
council directives into national law [22]. However, the afore-mentioned directive
being relatively recent, the current Finnish legislation on radiation protection is
still based on the predecessors of the directive. The Directive 2013/59/Euratom is
to be implemented into the national laws of the EU member states by 6th Febru-
ary 2018 [23]. Of the predecessors, the MED directive, i.e. the Council Directive
97/43/Euratom, pertains to medical exposures and contains the above-discussed
general principles as well as the requirement of adopting DRLs [111]. Furthermore,
the European Commission (EC) gives further clarification on the concept of DRLs as
well as advice on the determination and employment of DRLs in its publication ”Ra-
diation Protection 109”. However, the purpose of the afore-mentioned publication
is advisory and thus, the guidance provided in the publication is not binding. [24]
In the current Finnish legislation, the principles of justification and optimisation are
found in the Radiation Act [78] and the Decree of MSAH on the medical use of radi-
ation [19]. The obligation to apply DRLs is included in the afore-mentioned decree
of the MSAH. The decree also stipulates that DRLs are established by STUK. [19]
Moreover, by the Radiation Act, STUK is authorised to issue general instructions
that enable compliance with the act [78]. The instructions are provided in Radiation
Safety Guides (ST Guides), each of which contains safety requirements for a speci-
fied area of radiation practices [77, p. 299; 83; 85]. The role of STUK is discussed
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more closely in the following subsection. Due to the implementation of the new BSS
Directive, the Finnish legislation on radiation protection will be completely revised
by February 2018. All the afore-mentioned pieces of Finnish legislation as well as
the ST Guides will be affected by the law reform. [10]
3.2.2 Radiation and Nuclear Safety Authority in Finland
The authority responsible for supervising the use of radiation in Finland is STUK. In
matters concerning the medical use of radiation, STUK acts under the MSAH. [78]
The role of STUK in radiation protection is stipulated in the Finnish legislation.
The responsibilities of STUK include controlling the use of radiation and radiation
practices with respect to safety, conducting research and development activities,
providing expert services, supplying information and producing publications as well
issuing general instructions pertaining to radiation safety and participating in inter-
national co-operation within the field of radiation protection. In addition, STUK
monitors radiation levels across Finland, sustains preparedness for abnormal situa-
tions involving radiation as well as maintains a measurement standard laboratory. [6]
As an organisation, STUK comprises three regulatory departments and one depart-
ment concerned with monitoring environmental radiation and maintaining emer-
gency preparedness as well as departments of administration and public affairs [81].
One of the regulatory departments is focused on the regulation of radiation prac-
tices, namely the Department of Radiation Practices Regulation (STO), whereas
the other two are responsible for matters related to nuclear energy [81], which is out
of the scope of this work. The regulatory operations of STO encompass granting
safety licences, conducting regular inspections at facilities employing radiation, re-
ceiving and processing reports on abnormal events related to the use of radiation,
publishing and updating ST Guides as well as issuing DRLs [11, pp. 3, 5, 9].
3.2.3 Safety Requirements for Cone-Beam Computed Tomog-
raphy
As mentioned previously, STUK issues safety requirements in the form of ST Guides
[85]. The requirements concerning CBCT examinations are laid down in ST 3.1:
Dental X-ray examinations in health care [93]. For the study at hand, the most
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relevant aspects of ST 3.1 are the following: the requirement of a safety licence as
well the specific requirements imposed on the qualifications of the people responsible
for CBCT examinations and of those performing the examinations.
The use of CBCT devices is subject to licence. The required licence is a safety
licence (In Finnish Turvallisuuslupa) granted by STUK. A CBCT device can be put
into operation only after a licence has been obtained. To acquire a licence, the place
of use must submit an application to STUK with information on the radiation user
and the place of use. The information regarding the place of use should encompass
contact details as well as descriptions of the CBCT device or devices as well as the
facilities and their structural radiation protection. [93] Furthermore, each place of
use must assign a radiation safety officer that is in charge of ensuring the safety of
the radiation practices of the facility in question [89]. The radiation safety officer
must also be named in the application for the safety licence [93]. Based on the
granted safety licences, STUK maintains a register of all CBCT and other medical
X-ray devices in Finland.
In ST 3.1 STUK also sets specific requirements for the dentists and physicians re-
sponsible for CBCT examinations as well as for the personnel performing the exam-
inations. Of the dentists and physicians in charge of the examinations, it is required
that they are specialists in oral radiology or radiology. Moreover, dentists (licentiates
of dentistry) and physicians (licentiates of medicine) without the foregoing special-
ities can serve as dentist- or physician-in-charge after completing a supplementary
training course concerning CBCT examinations and passing a written examination
based on the course contents. To be allowed to conduct CBCT examinations, one
must either be a specialist in radiology or oral radiology, or a radiographer. Addition-
ally, dentists, physicians as well medical and dental specialists with a speciality other
than radiology or oral radiology who have the afore-mentioned supplementary train-
ing in CBCT can perform CBCT examinations. [93] Furthermore, dental hygienists
and dental assistants become eligible to conduct CBCT examinations by taking a
supplementary training course on CBCT aimed at the foregoing occupational groups
and successfully completing a skills test associated with the course [80, 93]. As an
additional requirement, the dentist- or physician-in-charge has to be available during
an examination performed by a dental hygienist or dental assistant [93].
The requirement of supplementary training in CBCT concerning the dentists and
physicians responsible for the examinations as well as the dental hygienists and
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assistants conducting the examinations was introduced in 2011 in ST 3.1 of that
time. A transition period of two years was given to enable the implementation of
the requirement. The transition period ended 1st October 2013. [90]
3.3 Diagnostic Reference Levels
The first priority in medical examinations is to fulfil the medical purpose, for which
the examination has been prescribed [44, p. 35]. Thus, restricting patient dose by
means of strict dose constraints or limits is not appropriate and can even entail
harmful consequences if obtaining the required diagnostic information is compro-
mised [46, pp. 87, 126]. Having said that, the patient should not be exposed to any
extra radiation that is not necessary for attaining the diagnostic information [111].
Hence, there are grounds for monitoring and managing the dose received by pa-
tients [43, p. 15].
To aid the management of patient dose, ICRP has created the concept of DRLs [44,
p. 35]. ICRP took preliminary steps towards DRLs in its recommendations of 1990,
in which considering the use of dose constraints or investigation levels for some
common diagnostic procedures was suggested. Although the term ”constraint” was
used, the recommendations allowed the constraints or levels to be exceeded if such
doses were clinically justifiable. [42] The actual concept of DRLs was introduced by
ICRP in Publication 73 in 1996 [43]. In 2002 ICRP published supporting guidance
to elucidate the purpose and the possible uses of DRLs [44]. Additionally, ICRP
Publication 105 provides a summary of the guidance on DRLs given by the earlier
publications [45]. Moreover, DRLs are included in the ICRP 2007 recommendations
[46]. Different aspects of DRLs are examined in the following subsections.
3.3.1 Concept and Uses
The ICRP outlines that the objective of DRLs is to protect patients from radiation
that is of no benefit for fulfilling the medical purpose of the examination or proce-
dure. The application areas of DRLs are diagnostic radiology and nuclear medicine.
Rather than providing a rigid definition of the term DRL, the ICRP publications
give a concept or a framework that allows for latitude in implementation. [44, pp.
34–35, 48]
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DRLs are numerical values that represent a percentile point in a patient dose distri-
bution based on national, regional or local data [44, pp. 36, 48, 51]. DRLs should be
issued for common examination types [43, p. 24]. The idea of DRLs is to enable the
detection of unusually high dose values. To achieve the foregoing, the facilities using
radiation for medical purposes should monitor their patient doses and compare a
set of dose values to the DRLs. If the mean value or other appropriate reference
value derived from the set of dose values is consistently higher than the DRL for
the examination type in question, the place of use should evaluate their equipment
and the methods employed with respect to optimisation. If shortcomings are found,
pertinent measures should be taken to rectify them. [43, p. 23] It is important to
note that DRLs are not applied to individual patients and thus, the value being
compared to the corresponding DRL is always based on dose values from a group of
patients, as described above [44, p. 48].
According to ICRP, also unusually low dose values should be identified because
they can indicate unsatisfactory image quality. Yet, the ICRP acknowledges that
the foregoing is not straightforward since dose is not the only factor contributing to
image quality. Therefore, the formation of DRLs that would detect too low doses for
sufficient image quality can be challenging. However, it is still stated in the ICRP
recommendations that if the observed doses consistently lie considerably below the
DRLs, the assessment of image quality should be triggered. [43, p. 24]
In general, DRLs are intended to be used in an advisory manner and not for reg-
ulatory purposes, for example. The ICRP describes three types of uses, for which
DRLs can be employed. At national, regional or local level, DRLs can be used to
shape dose distributions by removing doses from the top and low ends of the dis-
tributions. In the case of medical examinations, for which the clinical purpose is
exactly specified and the technique employed is defined at a general level, DRLs can
contribute to narrowing the dose range that is regarded as representative of good
practice. Finally, at the most specific level, DRLs can advance the achievement of
an optimum dose range for an imaging protocol that has explicit specifications and
is employed at a particular place of use. [44, pp. 36, 48–50]
3.3.2 Adoptions in Europe
The ICRP recommends the application of DRLs and provides a framework for them.
However, the task of further specifying the concept of DRLs as well as implement-
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ing the DRLs is delegated to regional, national and local authorised bodies. [44, pp.
33–35] At regional level in Europe, DRLs have been adopted in the MED directive.
For diagnostic radiology, the afore-mentioned directive defines DRLs as ”dose lev-
els in medical radiodiagnostic practices [. . .] for typical examinations for groups of
standard-sized patients or standard phantoms for broadly defined types of equip-
ment. These levels are expected not to be exceeded for standard procedures when
good and normal practice regarding diagnostic and technical performance is ap-
plied” [111]. The afore-mentioned definition has been transferred with slightly dif-
ferent wording but with essentially the same content to the Finnish legislation in
the decree of MSAH discussed previously [19].
To aid the establishment and implementation of DRLs in Europe, the EC provides
advisory guidelines in its publication ”Radiation Protection 109”. According to the
guidelines of EC, DRLs should be prepared by professional medical bodies and the
DRL values should be based on patient dose data originating from hospitals, clinics
and practices of different types. Each procedure type should receive its own DRL
due to differences between procedures. The DRL value should exceed the mean
or median of the dose distribution, based on which the DRL is set. A proposed
approach is to derive the DRLs from the 75th percentile values of the dose distribu-
tions. The rationale behind the proposal for using the 75th percentile is that patient
dose distributions are typically skewed with a ’tail’ towards the higher doses. Thus,
the idea with the use of the 75th percentile is to target the ’tail’ of the distribution.
The DRLs are recommended to be given as dose area product (DAP) or entrance
surface dose (ESD) or in the case of CT, as weighted CT Dose Index (CTDIW) and
dose length product (DLP). [24, pp. 8, 11]
Regarding the appropriate use and interpretation of DRLs, the EC guidelines state
that DRLs do not separate practices into good and bad or examinations into those
conducted well and badly. Thus, exceeding the DRL does not necessarily imply
that the examination was performed badly. Neither does the dose being lower than
the DRL mean that good practice was applied, because the image quality may be
insufficient. DRLs should be reviewed at such intervals that allow for stability but
that are also frequent enough to react to changes in the dose distributions. The DRL
values are expected to become lower over the course of revisions, since DRLs should
be derived from dose distributions and the application of DRLs should remove the
highest doses from the distributions. [24, pp. 6,8, 9–10]
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According to the results of surveys conducted in the years 2007–2010 in conjunction
with the EU project Dose Datamed 2 (DDM2), DRLs have been taken widely into
use throughout Europe. Based on the data of DDM2, 72% of European countries
have issued DRLs for adult X-ray examinations. When examining the countries of
the EU and the European Free Trade Association (EFTA), i.e. Iceland, Norway,
Switzerland, the corresponding percentage is 81%. However, DRLs for paediatric
X-ray examinations are significantly less common, with paediatric DRLs being estab-
lished in only 39% of European countries and in 45% of EU and EFTA countries.
The majority of the DRLs are based, at least in part, on national dose surveys,
whereas in some countries published values, recommendations or European DRLs
have served as a base for the DRLs. The 75th percentile approach had been em-
ployed for the derivation of the DRL values by all of the respondents, who had used
national dose data and who had reported their methods. [27, pp. 3, 7]
3.3.3 Diagnostic Reference Levels in Finland
The application of DRLs is a well established practice in Finland. The first Finnish
DRLs came into effect in the year 2000 [86] and to date, STUK has issued DRLs
for six different examination or procedure types [84]. The foregoing examination or
procedure types comprise cardiac radiology [88], nuclear medicine examinations [95],
CT examinations and conventional X-ray examinations of adults [91, 92] as well as
paediatric CT examinations and conventional X-ray examinations [87, 96]. The list
will be complemented by the DRLs for CBCT examinations of the head and neck
region subsequent to the publication of this study.
The DRLs for adult CT and conventional X-ray examinations as well as those for
nuclear medicine examinations have undergone rounds of revision after their initial
establishment [91,92,95]. When comparing the DRLs for conventional X-ray and CT
examinations from 2000 to the current ones, significant decreases in the DRL values
are observed [86,91,92]. In the case of conventional X-ray examinations of adults, the
current DRL values are 40–56 % lower than the ones issued in 2000 when examining
values for comparable imaging projection types [86, 92]. The only exception to
the foregoing is the DRL value for panoramic tomography of the teeth and jaws,
which has stayed the same. Regarding adult CT examinations, the decrease in DRL
values ranges from 24 to 55% when DRL values for the examinations of certain body
parts expressed in DLP are considered. In addition to the body-part-specific values,
the current DRLs for adult CT examinations include indication-based DRL values,
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which were not in use when the first DRLs were issued and accordingly, cannot be
compared. [86,91]
As indicated by the discussion above, the Finnish DRL values for adult CT and
conventional X-ray examinations have decreased substantially during the course of
revisions. The current DRLs for the foregoing imaging modalities are based on dose
distributions obtained through national dose surveys [11, p. 9; 53; 32]. The DRL
values for CT examinations correspond to the 75th percentiles of the distributions
consisting of single patient dose values for each examination type (a particular body
part or indication) [53]. The 75th percentile was also used in forming the current
DRLs for conventional X-ray examinations but the values were derived from distri-
butions containing mean patient dose values for each X-ray device instead of doses
of individual patients [32]. The DRLs from 2000 considered above were not directly
deduced from Finnish patient dose data. Instead, the first DRLs for adult CT ex-
aminations were based on literature and DRLs from other countries and those for
conventional X-ray examinations were established by comparing Finnish dose data
with European and Nordic DRLs. [50,53] Thus, it is not known how the introduction
and application of DRLs for X-ray examinations has affected dose distributions in
Finland, or whether the observed fall in DRL values has been accompanied by an
actual removal of high dose values from the distributions.
3.3.4 Cone-Beam Computed Tomography
The ICRP has recently, in 2015, published a publication dedicated to radiologi-
cal protection in CBCT. The publication dictates that DRLs should be issued for
CBCT examinations. However, it is also noted that, thus far, advances towards the
realisation of DRLs for CBCT have been modest and hence, international DRLs for
CBCT have not been established. [98, pp. 42, 100] To the knowledge of the author,
national DRLs for CBCT have not yet been issued by any country either. Also the
afore-mentioned ICRP publication states that present data available pertaining to
DRLs for CBCT is scarce [98, p. 100].
At the time of writing, Finland is close to issuing DRLs for CBCT examinations of
the head and neck region. The Finnish DRLs are currently being prepared by STUK
based on the data and information obtained through this study. Some preliminary
approaches to DRLs were also found in literature. The foregoing approaches include
patient dose studies conducted in Japan [21] and Korea [33] as well as notably,
3.3. Diagnostic Reference Levels 32
an achievable dose (AD) set by the British Health Protection Agency (HPA) [35].
The AD issued by HPA is of particular significance because it was adopted in the
guidelines of the SEDENTEXCT consortium [102].
The HPA measured and collected patient dose data for 41 CBCT scanners in total
in conjunction with a project conducted to issue recommendations for the facility
design and the quality assurance of CBCT devices. The recommendations resulting
from the project were published in 2010. As a part of the recommendations, an
AD of 250 mGy·cm2 was issued for the placement of a single-tooth implant (upper
first molar implant) in adults. The AD was recommended to be employed as a base
for dose optimisation. The AD was determined based on the above-mentioned dose
data. However, the derivation of the AD differed from that of DRLs in that nor-
malised dose values were used instead of the actual data. The actual data had been
measured using different FOV sizes and had a dose range of over 2 000 mGy·cm2.
The original dose values were normalised to an area corresponding to a FOV of 4
cm x 4 cm, which was regarded as a FOV size commensurate with the indication,
i.e. imaging for single-tooth implant treatments. To the attain the AD, the 75th
percentile for the distribution consisting of the normalised values was determined.
The AD corresponds to the 33rd percentile of the non-normalised data. Due to
lack of data, an AD was not established for child examinations. However, the HPA
recommendations stipulate that children should receive their own DRLs and that in
the case of paediatric CBCT examinations, DRLs should be issued for the imaging
of a single impacted tooth (maxillary canine) in 12-year-old males. [35, pp. 1, 9–12]
Similar to the ICRP publication on CBCT, also the guidelines of the SEDENTEXCT
project state that DRLs should be applied to CBCT examinations. However, it is
also noted that extensive studies are still needed for the establishment of those. As
mentioned, the AD for the placement of a single-tooth implant proposed by the
HPA is included in the SEDENTEXCT guidelines. The guidelines promote the
application of the afore-mentioned AD until European or national DRLs for CBCT
examinations are available. [102, pp. 93–94]
In the Japanese study, the DAP doses of 21 CBCT scanners housed in dental offices
in Tokyo and nearby regions were investigated. The scanners were from five different
manufacturers. For the DAP measurements, the imaging parameters and settings
were set assuming the purpose of the examination was the imaging of an impacted
mandibular third molar, i.e. a wisdom tooth, and the patient was assumed to be a
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standard-sized adult. The obtained DAP values varied between 126.7 mGy·cm2 and
1 476.9 mGy·cm2. No suggestions for DRLs were given based on the study. Instead,
it was concluded that the establishment of DRLs still required more studies and that
future studies should examine different diagnostic questions and the appropriate
choice of imaging parameters for each diagnostic question. [21]
In the Korean study, dose measurement data was gathered from 14 CBCT units
used in university hospitals across Korea. For the measurements, the largest FOV
size capturing both the mandible and the maxilla was chosen from each device.
The resulting DAP doses ranged from 476 to 3 960 mGy·cm2 with the mean being
1 972 mGy·cm2. The dose corresponding to the 75th percentile of the obtained
distribution was 3 203 mGy·cm2, which was proposed as a DRL value for CBCT
examinations by the authors. The authors stated that DRLs should be provided in
such form that both the dose value and the FOV size are given. The suggested DRL
value was acquired using the FOV size 16 cm x 18 cm. [33]
3.3.5 Dose Quantity
The HPA recommends that DRLs for CBCT are given as DAP [35, p. 9], or kerma
area product (KAP) as the quantity is currently recommended to be referred to
as [99]. Additionally, the AD for CBCT examinations issued by the HPA is given
as DAP [35, p. 12]. Furthermore, the SEDENTEXCT guidelines state that dental
CBCT devices should display dose as DAP [26, p. 103].
DAP/KAP is a dose quantity that describes the energy transferred from the X-ray
beam to the patient [105]. The quantity was previously defined in terms of absorbed
dose in air, which in turn, refers to absorbed energy per mass unit of air at a certain
point. However, the absorbed dose in air cannot be measured experimentally. What
is actually detected, is the air kerma and therefore, the quantity has been redefined
in terms of air kerma. [99] Ionising radiation results in the formation of charged
particles that receive kinetic energy. Air kerma is the kinetic energy received by the
charged particles in conjunction with their formation divided by unit mass of air.
[57, pp. 69–70; 99] That said, at beam energies employed in diagnostic radiology, the
energy of the charged particles is absorbed near the place of their formation [34, p.
115]. Consequently, the absorbed dose in air and air kerma are very close to equal
at those energies. Thus, in the context of diagnostic radiology, DAP and KAP can
be considered being the same quantity. [109, p. 123]
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In addition to air kerma, KAP takes into account the size of the X-ray beam. KAP
is obtained by integrating air kerma over the cross-sectional area of the X-ray beam,
as shown by Equation ( 3.1):
KAP =
∫
A
Ka(x, y) dx dy , (3.1)
in which Ka is the air kerma at point (x, y) and A the cross-sectional area of the
beam. [110] The unit of KAP is Gy·cm2 [105].
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4. MATERIALS AND METHODS
The study was conducted as a survey among parties conducting CBCT examinations
of the head and neck region in Finland. The chapter describes how the survey was
performed as well as how the obtained data was processed.
4.1 Collection of Data
The data for the study was collected employing a self-designed and formulated ques-
tionnaire, which was in the form of an Excel sheet. The target group of the survey
was the facilities performing CBCT examinations of the head and neck region in
Finland. The questionnaire was sent and responses were received by email. De-
tailed descriptions of the target group and the questionnaire are provided in the
following subsections. Moreover, the schedule concerning the sending out and the
response period of the survey as well as the response rate are discussed in the first
subsection.
4.1.1 Target Group, Schedule and Response Rate
The study targeted Finnish facilities performing CBCT examinations of the head
and neck region. The target group was further specified to only include the facilities
conducting CBCT examinations with a CBCT scanner or scanners registered by
STUK as the type ”Other dental X-ray device with the qualifier CBCT” (in Finnish
Muu hammasröntgenlaite, tarkenne kartiokeilatietokonetomografia (KKTT)). Thus,
among others, so called extremity CBCT scanners also applied to imaging of areas
other than the extremities (including Planmed Verity® and equivalent scanners)
were excluded from the study.
For the survey, a listing of the safety licences containing dental CBCT devices in
Finland was retrieved from the register maintained by STUK. At the time of re-
trieval, in April 2015, the aforementioned listing encompassed in total 73 places of
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use and 78 CBCT devices. Regarding one of the devices on the listing, there was
information available that the 3D imaging modality was not in use and therefore,
the device and its safety licence holder were removed from the listing. The ques-
tionnaire was sent by email under the name of STUK to the radiation safety officers
of the safety licences included in the above-mentioned listing. The questionnaire
was accompanied by a cover letter with an explanation of the purpose of the study
as well as with detailed instructions for the completion of the questionnaire. The
questionnaire and the cover letter are discussed in more detail in the next subsection.
The survey was sent out on 6th May 2015 and the completed questionnaires were
asked to be returned by 22nd May 2015. A reminder about the survey was sent on
22nd May 2015 to those who had not responded by then. Due to several requests for
additional time and a considerable amount of responses being submitted after the
end of the initial response period, eventually all completed questionnaires received
by the end of June 2015 were included in the study.
Completed questionnaires were received from 41 places of use and for 43 CBCT
devices out of the 72 and 77, respectively, found on the listing, based on which
the questionnaires were sent. Thus, the response rate, in terms of listed places of
use that returned a completed questionnaire or questionnaires, was 57% and that,
in terms of completed questionnaires per listed devices, was 56%. Furthermore,
regarding six of the listed devices, it was informed that the device was either only
employed for imaging phantoms, the device had not been installed or that no or
only a few images had been taken using the device and therefore, no survey forms
had been completed for those devices.
Additionally, completed survey forms concerning five CBCT devices outside the
listing were received. One of the devices was an extremity CBCT scanner and thus,
the information regarding that device was excluded from the study. The remaining
four devices were dental CBCT scanners and were accordingly included in the study.
Despite being of the desired type for the study, the last-mentioned CBCT devices
had not appeared on the listing retrieved for the survey because one of the scanners
had been mistakenly registered as another type of device, whereas the rest were trial
devices owned by the manufacturers and included in their safety licences. Thus,
considering the foregoing, completed survey forms were acquired altogether from
43 places of use and for 47 CBCT scanners regarded as falling within the intended
scope of the study.
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STUK Register
78 CBCT devices
73 places of use
Final Listing
77 CBCT devices
72 places of use
Completed
questionnaires
regarding 43
(56%) CBCT
devices & 41
(57%) places
of use out of
those listed
(final listing)
6 of the listed
devices not in
clinical use/only a
few images taken
Completed
questionnaires
regarding 5
CBCT devices &
3 places of use
outside the listing
Responses Included in Study
47 CBCT devices
43 places of use
Received Information
1 CBCT device & place of use removed
Questionnaires sent based on the listing
1 CBCT device (extremity scanner) &
place of use excluded
Figure 4.1 The process of data collection from retrieving the listing of the CBCT devices
and places of use of interest to determining the survey responses included in the study.
The flowchart in Figure 4.1 summarises the above-discussed process of data collec-
tion from the retrieval of the listing of the CBCT devices and places of use to be
studied, through categorisation of the received information, to the determination of
the survey responses accepted for the study. Furthermore, the exact numbers of the
CBCT devices and places of use at each stage are illuminated.
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4.1.2 Questionnaire
The aim of the questionnaire was to obtain data for indication-based DRLs. Besides
the actual dose data, examination frequencies per indication and the use of optimised
imaging parameters were of interest. Furthermore, the qualifications of both the
dentists or physicians responsible for the imaging examinations and the personnel
performing the examinations were surveyed. The questionnaire was in the form of an
Excel sheet and consisted of two sections elaborated below. The English translation
of the questionnaire is presented in Appendix A. Questionnaire. The language of
the original questionnaire was Finnish.
The questionnaire was sent with a cover letter containing information on the obli-
gation to apply DRLs to medical X-ray examinations and on the aims of the survey.
Moreover, instructions for the completion of each field of the questionnaire form and
contact information for questions were included in the letter. The English transla-
tion of the letter is provided in Appendix B. Cover Letter.
The respondents were asked to complete a separate questionnaire form for each
CBCT device. In the first section of the questionnaire, the following information
regarding the respondents and their CBCT devices was requested: the safety licence
number, the place of use, the manufacturer and model of the CBCT device, the
filtration of the device and information on the qualifications mentioned above. The
second and main section of the questionnaire comprised a table for the dose data.
The above-mentioned table contained a pre-filled list of indications for CBCT ex-
aminations of the head and neck region. The list is further discussed below. The
respondents were requested to complete the table with respect to the indications,
for which imaging was performed at their place of use. Concerning each indication,
the table included fields where the reading of the dose display of the CBCT scanner
and the error of the display were to be filled in. The dose reading was to be given as
DAP. In addition, the table encompassed fields for the imaging parameters and set-
tings that had been employed to obtain the given dose reading. The afore-mentioned
imaging parameters and settings are specified later in the subsection. The informa-
tion regarding the dose as well as the imaging parameters and settings was asked
to be filled in assuming the patient was an average-sized male with the exception
of the indications marked with the text ”children” in parentheses. Regarding the
last-mentioned indications, the afore-mentioned information was to be given for a
patient typical of the indication in question. Also the age of the typical patient
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was asked to be provided. Moreover, the respondents were requested to report the
estimated number of examinations per month for each indication.
The formation of the list of indications was a two-phase process. A preliminary list of
indications was formed through searching the literature and the websites of Finnish
dental clinics performing CBCT examinations. The preliminary list serving as a
basis, the final list was compiled by two experts: a specialist in oral radiology and a
specialist in dentomaxillofacial radiology. The final list encompassed 26 indications
in total. The indications are listed in Table 4.1. In the questionnaire form, the
indications were classified into five groups: 1) dentition and jaw area, 2) paranasal
sinuses, 3) cervical spine area, 4) temporal bone and 5) others. In the Excel table,
the classification was indicated by colour coding.
Information on the imaging parameters and settings employed was collected to en-
hance the assessment and analysis of the dose data. The imaging parameters re-
quested in the questionnaire were the following: the tube voltage, tube current, the
voxel size or resolution setting, FOV size and the scanning or exposure time. The
FOV size was asked to be given in the form FOV diameter times FOV height. The
imaging settings to be provided included the patient size setting and the name of
the employed imaging programme of the device. Furthermore, regarding the imag-
ing parameters and settings, it was enquired, whether those used were optimised or
factory default settings.
4.2 Data Analysis
The data received in the form of the questionnaire responses was manually trans-
ferred and compiled into an Excel file in an indication-specific manner. The compiled
file comprised the places of use, where imaging was performed for each indication
and the dose readings reported by the afore-mentioned facilities. Furthermore, re-
garding each dose reading, the following data was included in the file: error of the
dose display, the diameter and height of the FOV used, the manufacturer and model
of the CBCT device as well as information on whether optimisation was conducted.
In cases of the returned questionnaires being incomplete or containing equivocal
information, the respondents were contacted by email or telephone to request the
missing data or to ask clarifying questions. However, not everyone responded, and
consequently, some data was excluded from the data compilation. Cases leading to
the exclusion of data are discussed in the first subsection below.
4.2. Data Analysis 40
The compiled data was read into the technical computing software MATLAB R2015b
for analysis. First, the reported dose readings were corrected for display error in a
manner described in Subsection 4.2.2. To form the proposals for the DRLs, the data
on each indication was to ideally contain one dose value per CBCT device. However,
within some indications, some places of use had given more than one dose reading or
a dose range due to imaging being conducted with several protocols, including dif-
ferent FOV sizes and resolutions. In most such cases, a selection was made between
the given alternatives. The selections and the rationales behind them are explained
in Subsection 4.2.3. The dose values corresponding to the non-selected alternatives
were excluded from the further data analyses. The latter comprised examining dose
as a function of the manufacturers of the CBCT devices as well as studying the effect
of optimisation on dose. The afore-mentioned analyses are described in Subsection
4.2.5. Furthermore, the indication-specific estimations of the number of examina-
tions, i.e. the examination frequencies, as well as the qualifications of the people in
charge and the personnel conducting the examinations were collected from the com-
pleted questionnaires and analysed separately. Subsections 4.2.6 and 4.2.7 present
how the afore-mentioned information was registered.
4.2.1 Discarded Data
As mentioned previously, unclarity in the received information was one of the causes
resulting in exclusion of data from the results. This was the case with some of the
dose readings reported for the indication ”Presurgical imaging of implant treat-
ments”, which consisted of two subindications: ”imaging of areas with a single miss-
ing tooth” and ”imaging of the maxilla or mandible”. The subindications were in-
tended to be treated separately when completing the questionnaire form. However,
for the afore-mentioned indication, several respondents only gave one dose value
with its concomitant information on the imaging settings and parameters without
indicating, which of the subindications was in question. In those cases, the respon-
dents were asked to specify their answers. However, not everyone responded, which
lead to exclusion of the dose values, for which there was no information regarding the
subindication. On account of the foregoing, one dose interval and two dose values
were discarded.
Another reason for discarding data was that some of the reported dose data was
considered unreliable. The foregoing applied to dose values for two CBCT scanners
that lacked a DAP display. Because the eventual proposals for DRLs were to be
4.2. Data Analysis 41
given as DAP, also the calculations forming the basis for the proposals were to be
conducted using DAP values. Despite the lack of a DAP display, the dose values
for both of the afore-mentioned devices were reported as DAP. However, in one
of the cases, the reported DAP values were approximations derived from another
dose quantity using a method failing to conform with the definition of DAP. In
the other case, there was no information on how the DAP values were determined
and additionally, the values differed significantly from those previously measured by
STUK. Therefore, all the dose data for the afore-mentioned two CBCT units was
excluded from the study.
4.2.2 Dose Calculations
In the questionnaire, the respondents were asked to report the radiation dose as
indicated by the dose display of the CBCT scanner. Due to error present in dose
displays, the dose readings from the scanners do not fully represent the true dose.
Hence, to better approximate the true dose, the reported dose readings were cor-
rected utilising information on the error of the dose displays. The corrected doses
were calculated using Equation ( 4.1):
dosec =
dosed
errord + 1
, (4.1)
in which dosec is the corrected dose, dosed the dose reading of the scanner display
and errord the error of the dose display. The variable errord is a signed value:
a positive sign implying that the dose reading of the display is higher than true
or measured dose and a negative sign implying the opposite. Information on the
error of the display was acquired from the completed survey forms as well as from
logbooks of measurements conducted by STUK. Sources for the error data reported
by the respondents included data from measurements performed by maintenance
companies, device suppliers and STUK.
For the data on the error of the display to be applicable, it was required that the error
had been measured using the same tube voltage and FOV size as was used when the
dose given in the survey response was determined. If error data measured by STUK
was available and it differed from the error values provided by the respondents,
the data of STUK took precedence. Moreover, the error values determined with a
resolution matching the one used by the respondents to obtain the reported dose,
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were preferred. However, the foregoing was not a requirement. Thus, if no error
data for the desired resolution was available or the data was unreliable, an error
value measured with a non-matching resolution was employed, provided that the
tube voltage and FOV size conformed with those required. If no information on the
error of the display was available or the error data failed to fulfil the afore-mentioned
requirements for the tube voltage and FOV size, the error was recorded as 0%, i.e.
the corrected dose was equal to the dose reading of the display.
4.2.3 Selection between Dose, Field of View Size and Reso-
lution Alternatives
As discussed previously, in cases where more than one dose value was provided
for a CBCT device within an indication, selections between the alternatives were
made. The alternative dose values mainly resulted from the employment of different
FOV sizes and resolution settings within indications. The selections were made in
two steps. First, from among the FOV sizes given for a CBCT device within an
indication, the one closest to those most commonly used within that indication was
chosen. The dose values corresponding to the selected FOV sizes were retained
in the file containing the compiled data, whereas those corresponding to the other
FOV sizes were removed from the compilation. Thereafter, all the other selections
were made. The principles according to which the most common FOV sizes were
determined as well as those underlying the other selections are described below.
The data collected regarding the FOV size comprised two variables: the FOV diam-
eter and height. However, the exact combinations of the FOV diameter and height
in the FOV size options of CBCT scanners vary considerably between manufacturers
and even between different models of the same manufacturer. Hence, the FOV data
in the form it was collected was not directly applicable to determining the FOV
sizes most commonly used. The problem was addressed by calculating the volumes
of the reported FOVs. Thereby, a single-value representation for the FOV size was
obtained, providing a means of comparison.
Based on manuals of the CBCT devices and other material acquired from the man-
ufacturers, the vast majority of the FOVs in the compiled data had the shape of a
cylinder. The remainder of the FOVs were spherical and originated from a single
device. Accordingly, the volumes of the FOVs, with the exception of the spherical
FOVs, were calculated using the volume formula for a cylinder. The spherical FOVs
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were not perfect spheres, but to obtain an approximation of their volumes, the vol-
ume formula for a sphere was utilised. Additionally, prior to the calculations, all
the FOV sizes reported by the respondents were reviewed for errors and corrected
using manufacturer-provided information on the FOV sizes available on each device.
The erroneous FOV sizes mainly resulted from the sizes being reported in the form
”height times diameter” instead of the requested ”diameter times height”.
To find the most common FOV sizes within each indication, indication-specific his-
tograms of the FOV volumes were produced in MATLAB. In cases where the afore-
mentioned histograms did not provide a clear distinction between the alternatives
being considered, also other size parameters were examined. More specifically, the
FOV diameters and heights were analysed as separate values, and also the numbers
of their exact combinations were studied.
The other selections included choosing between resolution alternatives. Due to wide
diversity in the resolution options and in their implementation between manufac-
turers and models [71], the resolution settings per se were considered incomparable.
Therefore, instead of the reported resolution settings, the dose values corresponding
to those were examined. Additionally, in one response alternative dose values were
given due to the use of different tube currents. To conduct the selections, indication-
specific dose distributions were plotted in MATLAB. The alternative dose values
were included in the distributions.
The selections based on the above-mentioned dose distributions were made according
to the following principles:
• Alternatives located at the edges of the dose distribution and clearly differing
from the dose values in the middle parts of the distribution were excluded from
the results.
• If the foregoing applied to none of the alternatives being considered, all of the
alternatives were included in the results.
In all cases there were two dose alternatives. The latter principle on the list above
applied to all except for one case. There were no instances where both of the dose
alternatives would have been situated at the edges of the distribution.
Furthermore, some respondents had given a dose range covering alternative imaging
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protocols with different imaging parameters and settings as well as their combina-
tions. The dose ranges were addressed by taking the endpoints of the intervals and
handling them as separate values. The endpoints were then mirrored against the
afore-mentioned dose distributions. The endpoint of each range with a value closer
to the dose values forming the middle region of the distribution was included in the
results.
4.2.4 Proposals for Diagnostic Reference Levels
Proposals for the indication-based DRLs in CBCT examinations were formed based
on the obtained dose data that was corrected for display error, as described in
Subsection 4.2.2. In forming the proposals, the following aspects were considered:
the number of data points and the imaging frequency of each indication, the form
of the indication-specific dose distributions as well as the convention of applying
percentiles of dose distributions to the establishment of DRLs [27,59]. Additionally,
desired characteristics of the eventual DRLs included that all the DRLs were to
correspond to the same percentile.
First, the data for each indication was assessed with respect to the number of data
points. Thereafter, the dose distributions of the indications with a sufficient amount
of data points were visualised in MATLAB. Lines indicating three different per-
centiles of each dose distribution, the 75th, 80th and 85th percentile, were also
incorporated into the afore-mentioned plots. The values corresponding to the per-
centiles were determined by applying the function prctile in MATLAB to the
indication-specific dose data. The algorithm behind the function is explained below.
The function prctile sorts the given input data values in ascending order and
assigns the following percentiles:
100
0.5
n
th, 100
1.5
n
th, ..., 100
n− 0.5
n
th, (4.2)
in which n is the number of the input data values. The sorted input data values
are the percentile values corresponding to the percentiles presented in ( 4.2). To
determine percentiles lying between those given in ( 4.2), the function employs linear
interpolation according to Equation ( 4.3):
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y = f(x) = y1 +
x− x1
x2 − x1 (y2 − y1) , (4.3)
in which (x1, y1) and (x2, y2) refer to data points, for which y1 = f(x1), y2 =
f(x2), and x is a value located between x1 and x2. The values corresponding to the
percentiles falling outside the range of those presented in ( 4.2 ) equal the minimum
and maximum values of the input data. [58]
The graphs of the dose distributions with the above-described percentiles were evalu-
ated by visual inspection. Based on the visual inspection and considering the above-
discussed aim of using the same percentile for all indications, the 75th percentile
was deemed the most applicable to the DRL proposals being prepared. To form the
final proposals for the DRLs, the values corresponding to the 75th percentiles were
rounded up to the nearest ten. Finally, it was assured that the imaging frequencies
of each of the selected indications were sufficient for the establishment of DRLs to
be reasonable.
4.2.5 Further Analyses on Dose
Further analyses on the dose data encompassed examining the effect of optimisation
and the manufacturer of the CBCT device on the dose produced. It was also studied,
whether differences existed between different models of the same manufacturer with
respect to dose.
Regarding optimisation, a dichotomous response option (O/F) was given in the
questionnaire: O implying optimisation of the imaging settings and F referring to the
use of factory default settings. Based on the answers, the letter indicating the chosen
optimisation option was added for each dose value in the data compilation file. Due
to responses where information on optimisation was absent or the answers differed
from the pre-defined response options, a third category, namely ”U = undefined”,
was adopted for analysis purposes. In the case of one CBCT device included in
the study, the question on optimisation was considered irrelevant since the device
employed automatic exposure control. Accordingly, the optimisation information
concerning the foregoing device was entered as U in the data compilation. The
same three categories are used in presenting the results regarding optimisation in
Section 5.3.1 Effect of Optimisation on Dose.
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The effect of the manufacturer and model on dose was inspected in a manner akin
to that used for optimisation. The information on the manufacturers and models
of the CBCT scanners used by the respondents was collected from the completed
questionnaire forms. The afore-mentioned information was then registered alongside
each dose value in the file comprising the compiled data.
4.2.6 Examination Frequency
The examination frequencies were requested to be reported as the estimated number
of examinations per month for each indication. The frequencies were also registered
and compiled for analysis in the same form. In cases where the respondents had given
the frequencies in another form than that requested, the frequencies were converted
to the desired form. Deviations from the requested form and the principles according
to which the conversions were made are listed below.
• Examination frequencies given in the form ”less than x”, where x is an integer,
were set to x.
• Frequencies reported in the form ”approximately x”, where x is an integer, were
registered as x.
• When a range was provided, the mean value of the endpoints of the range was
taken.
• When a frequency was reported as the number of examinations per year or
per two years, the reported frequency was divided by 12 or 24, respectively.
Additionally, there were three respondents whose answers concerning the examina-
tion frequencies were such that the above-listed principles were not applicable and
the answers were thus assessed individually. One of the afore-mentioned respondents
reported some of the examination frequencies qualitatively using the word ”some-
times”. The foregoing frequencies were registered as 0 in the data compilation. Yet,
the place of use in question was taken into account when examining the places of
use where imaging was performed for each indication, which is discussed at the end
of the subsection.
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One of the individually assessed survey responses was completely devoid of exam-
ination frequencies but they were obtained on request. However, the acquired fre-
quencies were not given indication-specifically but for three categories: ear, sinuses
and dentition. In the survey response, the respondent had completed information
regarding one ear- and one sinus-related indication as well as regarding two indica-
tions pertaining to the dentition. The frequencies provided for the categories ear
and sinuses were directly assigned to the ear- and sinus-related indications, respec-
tively. Since no information was available on how the examination frequencies were
distributed between the two dentition-related indications, the frequency given for
the category dentition was divided half and half between the indications.
In the third case, the respondent had given a total examination frequency (6 ex-
aminations per month) covering four indications. Accompanying the frequency was
information that for one of the indications, imaging was performed less frequently
than for the other three indications. Due to lack of better information, the fol-
lowing arbitrary frequencies were allocated to the indications: 0.75 examinations
per month to the less frequent indication and 1.75 examinations per month to each
of the remaining three indications (adding up to the reported total frequency of 6
examinations per month).
If indication-specific examination frequencies were provided in the responses, they
were included in the results even if other information concerning the indication, i.e.
the imaging parameters and settings, and dose, was missing or incomplete. In cases,
where dose values had been discarded, the examination frequencies were accepted
for the results nevertheless.
The combined number of examinations per month was calculated for each indica-
tion separately. However, individual examination frequencies were not determined
for the subindications constituting the indication ”Presurgical imaging of implant
treatments” because all respondents did not itemise the frequencies between the
subindications within that indication. Examination frequencies reported as dec-
imals and non-integer frequencies resulting from the above-described conversions
were included in the calculations without rounding. The computed sums were then
rounded to nearest integers to obtain the indication-specific total numbers of exam-
inations presented later in the results.
In addition to the examination frequencies, the number of the places of use where
imaging was performed, was registered for each indication. There were two survey
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responses where the examination frequency of an indication/indications was marked
as 0 or was missing although dose and the other requested information had been
completed concerning those indications. Regarding the foregoing responses, it was
assumed that imaging was performed for the indications in question but the fre-
quency was less than one examination per month or that no examinations had been
conducted thus far but the place of use was planning or at least had the prepared-
ness to do so. Hence, in the afore-mentioned cases, the places of use were included
in the number of facilities performing examinations for that indication/indications.
Moreover, as noted previously, in the case of one respondent, qualitatively reported
examination frequencies were registered as 0 but the place of use in question was
included when determining the number of the places of use.
4.2.7 Qualifications
The respondents were requested to report the qualifications of the people in charge of
the imaging examinations as well as those of the personnel performing the examina-
tions. The information regarding the qualifications was analysed by examining the
occupational groups mentioned in the survey responses. From the reported occupa-
tional groups, categories were formed based on the assumed radiological knowledge
of each occupational group. The aim was that within each category, the level of
radiological knowledge between the members would be approximately the same.
Some categories were composed by combining occupational groups, whereas some
categories comprised a single occupational group.
The categories regarding the people responsible for the examinations are listed be-
low:
• specialists in radiology or oral radiology (In Finnish radiologit/radiologian
erikoishammaslääkärit)
• dentists (licentiates of dentistry), physicians (licentiates of medicine), medical
and dental specialists with a speciality other than radiology or oral radiology.
The corresponding categories for the personnel performing the examinations were
the following:
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• specialists in radiology or oral radiology (In Finnish radiologit/radiologian
erikoishammaslääkärit)
• dentists (licentiates of dentistry), physicians (licentiates of medicine), medical
and dental specialists with a speciality other than radiology or oral radiology
• radiographers (In Finnish röntgenhoitajat)
• dental hygienists (In Finnish suuhygienistit)
• dental assistants (In Finnish hammashoitajat).
It was assessed how the different categories were represented among the people in
charge as well as among those conducting the examinations. The assessments were
performed by determining the prevalences of the categories. In determining the
prevalences, each category was included only once per place of use, regardless of the
number of people belonging to that category.
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Table 4.1 Pre-filled list of indications used in the questionnaire.
Dentition, jaw
area, airways
and cephalom-
etry
Presurgical imaging of implant treatments
a) imaging of areas with a single missing tooth
b) imaging of the maxilla or mandible
Assessment of the relationship between a wisdom tooth and the
mandibular canal
Jaw cysts and tumours
Tooth fractures
Alveolar fractures
Jaw or condylar fractures
Dysfunction of the masticatory system (TMJ area)
Orthognathic surgery
Localisation of unerupted and supernumerary teeth (excluding wis-
dom teeth) (children)
Cleft palate (children)
3-dimensional cephalometry
3-dimensional cephalometry (children)
Airway assessment
Obscure pain conditions
Assessment of the periapical region and the root canal morphology of
the tooth
Periodontal diseases
Paranasal
sinuses
Inflammatory changes, polyps and tumours of the paranasal sinuses
and the nasal meatus
Trauma of the paranasal sinuses (including orbital floor)
Cervical spine
area
Fractures of the cervical spine
Spondyloarthropathy of the cervical spine
Temporal bone
Anomalies and changes of the outer auditory canal as well as of the
inner and middle ear
Otomastoiditis
Assessment of inner or middle ear implant positioning
Others
3D modelling
Computer-aided surgical planning
Manufacturing of customised implants
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5. RESULTS AND ANALYSIS
The chapter presents the results of the study. Analysis of the results as well as
discussion on the importance of the findings are also included in the chapter. The
chapter is divided into four main parts. The first part presents the results pertaining
to the indications for CBCT examinations and the examination frequencies. There-
after, the findings on patient radiation dose are explored and the DRL proposals for
CBCT examinations of the head and neck region are presented. In the third part,
the effects of manufacturer and model as well as that of optimisation on dose are
discussed. Lastly, the results regarding the qualifications of the people responsible
for CBCT examinations as well as the qualifications of those performing the imaging
are examined.
5.1 Indications and Examination Frequency
The respondents of the dose survey were asked to estimate the number of examina-
tions performed at their place of use. The examination frequencies were requested
to be given as the number of examinations per month and for each indication sep-
arately. The sums of the reported monthly examination frequencies are shown in
Table 5.1. The table presents the frequencies in an indication-specific manner. All
the indications found on the pre-defined list of the questionnaire are included. The
indications are ordered according to their examination frequencies, with the most
popular indication at the top. The number of places of use, at which imaging is
conducted for each indication is also provided in the table. Furthermore, the exami-
nation frequencies are visualised by a bar chart in Figure 5.1. The indications with
monthly examination frequencies of 47 or more, i.e. the nine most popular indica-
tions, are presented in individual bars, whereas the bar entitled ”Others” represents
all of the remaining 17 indications.
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Figure 5.1 Examination frequencies. The names of the indications are presented in
abbreviated form. The correspondence between the abbreviated forms and the full titles
of the indications is the following: Implant treatments = presurgical imaging of implant
treatments, a) and b) together; Paranasal sinuses (excl. trauma) = inflammatory changes,
polyps and tumours of the paranasal sinuses and the nasal meatus; Periapical region =
assessment of the periapical region and the root canal morphology of the tooth; Wisdom
tooth = assessment of the relationship between a wisdom tooth and the mandibular canal;
Obscure pain = obscure pain conditions; TMJ area = dysfunction of the masticatory system
(TMJ area); Unerupted and supernumerary = localisation of unerupted and supernumerary
teeth (excluding wisdom teeth) (children). The bar entitled ”Others” represents the other
indications of the pre-defined list used in the dose survey.
5.1.1 Indications
Table 5.1 shows that out of the 26 indications on the pre-defined list of the survey,
there are only two indications, for which none of the respondent facilities reported
having performed examinations. However, the examinations are by no means spread
evenly across the indications. In terms of the number of examinations conducted,
only nine of the 26 indications account for 93% of all of the reported CBCT exami-
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nations of the head and neck region. There are also considerable differences between
the foregoing top nine indications, with four indications dominating over the others.
The nine most important indications in terms of examination frequency were, start-
ing from the most frequent, the following: 1) presurgical imaging of implant treat-
ments, 2) inflammatory changes, polyps and tumours of the paranasal sinuses and
the nasal meatus, 3) assessment of the periapical region and the root canal mor-
phology of the tooth, 4) assessment of the relationship between a wisdom tooth
and the mandibular canal, 5) jaw cysts and tumours, 6) obscure pain conditions,
7) dysfunction of the masticatory system (TMJ area), 8) localisation of unerupted
and supernumerary teeth (excluding wisdom teeth) and 9) tooth fractures. Among
the foregoing, the first four indications were dominant in that their examination
frequencies ranged from close to 200 to several hundreds per month, whereas those
of the remaining five were for the most part well below 100 per month.
The list of the most common indications can be interpreted so that the most signif-
icant application areas of head and neck CBCT in Finland are presurgical imaging
of the dentition (for implant treatments and for wisdom tooth extraction), imaging
of non-traumatic conditions of the paranasal sinuses and the nasal meatus as well
as the assessment of the tooth root canal and the areas surrounding the apex of the
root (the periapical region). It is also noteworthy that the indication ”localisation
of unerupted and supernumerary teeth” is among the most common indications be-
cause it only pertains to children and thus, its prevalence shows that children also
constitute an important patient group for CBCT examinations in Finland.
Examinations were conducted for almost all indications on the pre-defined list of the
survey. Moreover, no complaints regarding missing indications were received from
the respondents of the study. The foregoing aspects suggest that the pre-defined list
succeeded in comprehensively covering the application field of head and neck CBCT
in Finland.
5.1.2 Examination Frequencies
The total number of CBCT examinations per month was found to be approximately
1 670, which translates into roughly 20 000 examinations per annum. Because
over 40% of the facilities conducting CBCT examinations did not respond to the
dose survey and the variation between the facilities in terms of indications and
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numbers of examinations performed was found to be considerable, it is impossible
to extrapolate any estimates of the total nationwide number of examinations from
the values obtained through this study. However, it can be said that the order of
magnitude of the nationwide number of CBCT examinations appears to be tens of
thousands examinations per year.
STUK surveys periodically the annual numbers of radiological examinations and
procedures in Finland [48, p. 3]. The latest of the afore-mentioned surveys pertains
to the examinations and procedures performed in 2015, i.e. the same year the
data for this study was collected. Also CBCT examinations are included in the
foregoing survey. The survey is still ongoing and thus, the data for the study is not
published but preliminary data is available. At the time of writing, the response
rate is approximately 80% in terms of places of use with a licensed CBCT device or
devices. In the current preliminary data, the annual total number of dental CBCT
examinations as well as those of other parts of the head is 9 556. The foregoing
equals approximately 800 examinations per month.
The survey of STUK employs a different categorisation of the indications than this
study and therefore, indication-specific comparison of examination frequencies can-
not be made. However, one of the categories in the study of STUK, namely the
imaging of sinuses, is similar enough to enable comparison. The current preliminary
total number of examinations for the imaging of the sinuses in adult patients is 1 067
per year, i.e. roughly 90 examinations per month. Thus, according to the prelimi-
nary data, the portion of sinus examinations is 11% of all CBCT examinations. [82]
In the study at hand, combined number of examinations for the indications ”inflam-
matory changes, polyps and tumours of the paranasal sinuses and the nasal meatus”
and ”trauma of the paranasal sinuses (including orbital floor)” account for 20% of
all CBCT examinations.
As seen in the numbers presented above, the total number of CBCT examinations
in the study of STUK is approximately half of that reported by the respondents of
this study. Considering that the current response rate of the survey of STUK is ap-
proximately 80%, whereas that of this study was less than 60%, the actual difference
between the results of the two studies is even more substantial than the presented
numbers of examinations suggest. For the imaging of sinuses, the difference in ex-
amination frequency is even larger, with the frequency found by this study being
nearly 4-fold compared to the frequency obtained through the study of STUK. Also
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the relative amount of sinus examinations was approximately 9 percentage points
higher in this study than in that of STUK.
No clear reason can be identified for the substantial differences in the results of the
two surveys. Because the numbers of examinations acquired through this study are
based on estimations, overestimation is a possible explanatory factor. Furthermore,
monthly examination frequencies may vary significantly between months during the
year, which might not have been taken into account by the respondents of this
study. Thus, the reported monthly examination frequencies may not correspond to
frequencies that would be obtained by averaging annual frequencies by month but
rather represent frequencies of a particular month or months. Additionally, some re-
spondents might have accidentally provided annual examination frequencies instead
of monthly frequencies in the survey forms of this study. Based on the completed
questionnaires for this study, the places of use employing CBCT exhibit large diver-
sity in the numbers of examinations and imaging indications, which can contribute
to the observed difference in the relative frequencies of sinus examinations.
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Table 5.1 Indication-specific examination frequencies and the number of places of use, at
which imaging is performed for each indication. The total number of CBCT examinations
per month is given at the bottom of the table.
Indication ExaminationFrequency
Places
of Use
Presurgical imaging of implant treatments 536 38
Inflammatory changes, polyps and tumours of the
paranasal sinuses and the nasal meatus
329 21
Assessment of the periapical region and the root canal
morphology of the tooth
195 30
Assessment of the relationship between a wisdom tooth
and the mandibular canal
178 38
Jaw cysts and tumours 109 28
Obscure pain conditions 60 22
Dysfunction of the masticatory system (TMJ area) 54 12
Localisation of unerupted and supernumerary teeth
(excluding wisdom teeth) (children)
52 18
Tooth fractures 47 20
Jaw or condylar fractures 20 9
Cleft palate (children) 19 2
Alveolar fractures 18 12
Trauma of the paranasal sinuses (including orbital
floor)
10 5
Anomalies and changes of the outer auditory canal as
well as of the inner and middle ear
9 5
Computer-aided surgical planning 8 5
Spondyloarthropathy of the cervical spine 6 3
3D modelling 5 4
Assessment of inner or middle ear implant positioning 5 1
Manufacturing of customised implants 4 2
Periodontal diseases 3 3
Orthognathic surgery 2 2
Fractures of the cervical spine 2 1
Otomastoiditis 2 2
Airway assessment 1 1
3-dimensional cephalometry 0 0
3-dimensional cephalometry (children) 0 0
Total 1674
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5.2 Patient Radiation Dose and Proposals for Diagnostic Ref-
erence Levels
The section explores the results regarding the patient dose collation and presents the
DRLs proposals formed based on the collected data. The amount of the collected
data was sufficient for analysis in the case of seven indications, one of which consists
of two subindications. The indication comprising two subindications is the ”Presur-
gical imaging of implant treatments” with the subindications ”imaging of areas with
a single missing tooth” and ”imaging of the maxilla or mandible”.
5.2.1 Patient Radiation Dose
The patient dose data for the afore-mentioned seven indications is illustrated in
Figures 5.2 and 5.3. In the graphs of Figures 5.2 and 5.3, each blue circle
represents a single dose value corrected for display error in the manner described in
Subsection 4.2.2. The empty circles in the graphs correspond to the reported dose
values, i.e. non-corrected dose values provided by the respondents of the survey.
Both the corrected and non-corrected dose values are arranged in ascending order.
In each graph, a red horizontal line denotes the level of the 75th percentile of the
corrected data. The level of the 75th percentile is shown in the figures because the
DRL proposals provided in the study are derived from the foregoing percentile, as
discussed in the next subsection. Furthermore, descriptive statistics of the afore-
mentioned seven indications are given in Table 5.2. The values in Table 5.2 were
computed based on the error-corrected data.
Figures 5.2 and 5.3 show that the dose range is very wide for all of the explored
indications with maximum-to-minimum dose ratios ranging from 7 to an extreme
of 50. Of the foregoing maximum-to-minimum dose ratios, the lowest pertained to
the indication ”Assessment of the periapical region and the root canal morphology
of the tooth” and the highest to the indication ”Inflammatory changes, polyps and
tumours of the paranasal sinuses and the nasal meatus”. In the case of all but one
(”Localisation of unerupted and supernumerary teeth (excluding wisdom teeth)”)
of the indications and subindications, the mean was higher than the median. The
foregoing implies that the dose distributions contain a few values that are very high
in relation to the rest of the values, which is also seen in the graphs of Figures 5.2
and 5.3.
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As described in Chapter 4 Materials and Methods, as a rule, the dose data included in
the study for each indication consists of one dose value per CBCT scanner (with few
exceptions due to accepting multiple values corresponding to different resolutions).
Furthermore, the majority of the respondent facilities possess only one CBCT unit.
Hence, the dose range observed in Figures 5.2 and 5.3 can also be seen as the
dose variation between the places of use. Thus, the results show that the indication-
specfic dose the patient is exposed to can vary significantly depending on, where the
examination is performed. Such dose variation between facilities is not acceptable
and shows that there is an effective need for DRLs.
To evaluate the significance of the display error correction, the values corresponding
to the 75th percentiles of the corrected and non-corrected data were compared. It
was calculated, how much higher or lower the percentile values derived from the
non-corrected data were compared to those derived from the corrected data. At its
maximum, the difference was approximately 7% and it was in the direction of the
percentile value calculated from the non-corrected data being higher than that of
the corrected data. Also differences in the opposite direction were observed.
The order of magnitude of the above-described differences is such that the error is of
very small practical significance when considering the establishment of DRLs since
other error sources and factors are likely to have an considerably larger effect on
the eventual values for DRLs. The foregoing error sources and other factors include
errors in the dose readings provided by the respondents as well as the influence of
the selections that were made in cases, where the place of use had reported multiple
dose values within an indication. Moreover, most importantly, the determination
of the values for DRLs is not an exact science since the choice of the percentile is
mostly based on convention instead of the actual characteristics of the data and the
eventual DRLs are often obtained by rounding the exact values corresponding to
the chosen percentile.
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Figure 5.2 Indication-specific dose data, part 1. Corrected dose refers to the data cor-
rected for display error. Reported dose denotes the dose values given by the respondents.
Both data types are sorted in ascending order. The red horizontal line indicates the level
of the 75 the percentile of the corrected data.
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Figure 5.3 Indication-specific dose data, part 2. Corrected dose refers to the data cor-
rected for display error. Reported dose denotes the dose values given by the respondents.
Both data types are sorted in ascending order. The red horizontal line indicates the level
of the 75 the percentile of the corrected data.
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Table 5.2 Descriptive statistics of the dose data corrected for display error. Min and
Max refer to the minimum and maximum values of the data. All values have been rounded
to the nearest integer.
Indication Min(mGy·cm2)
Max
(mGy·cm2)
Mean
(mGy·cm2)
Median
(mGy·cm2)
75th
Per-
centile
(mGy·cm2)
1. Presurgical imaging
of implant treatments
a) imaging of areas
with a single missing
tooth
27 730 286 262 353
b) imaging of the max-
illa or mandible
72 1443 504 442 606
2. Assessment of the
relationship between a
wisdom tooth and the
mandibular canal
100 1443 394 284 376
3. Jaw cysts and tu-
mours
128 1340 450 357 491
4. Localisation of
unerupted and super-
numerary teeth (ex-
cluding wisdom teeth)
(children)
27 390 207 214 286
5. Obscure pain con-
ditions
98 2401 472 338 435
6. Assessment of the
periapical region and
the root canal mor-
phology of the tooth
197 1443 462 399 541
7. Inflammatory
changes, polyps
and tumours of the
paranasal sinuses and
the nasal meatus
48 2401 929 866 1146
5.2.2 Proposals for Diagnostic Reference Levels
Based on indication-specific number of data points, examination frequencies as well
as visual inspection of graphs akin to those presented in Figures 5.2 and 5.3 of the
previous subsection, seven indications with one indication comprising two subindi-
cations were deemed suitable for the establishment of proposals for indication-based
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DRLs. The DRL proposals are provided in Table 5.3. All of the proposed values
for DRLs are derived from the 75th percentile of the patient dose data that was
corrected for display error of the CBCT units.
Table 5.3 Proposals for indication-based diagnostic reference levels.
Indication DRL Proposal(mGy·cm2)
1. Presurgical imaging of implant treatments
a) imaging of areas with a single missing tooth 360
b) imaging of the maxilla or mandible 610
2. Assessment of the relationship between a wisdom tooth and
the mandibular canal
380
3. Jaw cysts and tumours 500
4. Localisation of unerupted and supernumerary teeth (exclud-
ing wisdom teeth) (children)
290
5. Obscure pain conditions 440
6. Assessment of the periapical region and the root canal mor-
phology of the tooth
550
7. Inflammatory changes, polyps and tumours of the paranasal
sinuses and the nasal meatus
1150
The quality of the acquired dose data and the proposed DRLs can be regarded as
complying well with the guidance on DRLs given by the ICRP and the EC. As
recommended by the ICRP [44, p. 51], the proposed DRLs are based on national
data and they are based on a percentile point of the dose distributions. Furthermore,
the data was obtained from both hospitals and dental clinics of different types and
sizes, which was one of the requirements imposed by the EC [24, p. 11].
Regarding the DRLs, the EC guidance states that different procedures should receive
their own DRLs [24, p. 8]. The proposed DRLs conform with the foregoing criterion
by being indication-based. Concerning the values for DRLs, the EC advises that
the values should be higher than the median or mean of the dose distributions and
suggests the use of the 75th percentile of the dose distributions [24, p. 11]. In
the case of five out of the seven indications, all of the foregoing characteristics are
met. For the indications ”Assessment of the relationship between a wisdom tooth
and the mandibular canal” and ”Obscure pain conditions”, the proposed DRL value
is lower than the mean but is nevertheless higher than the median. Figures 5.2(c)
and 5.3(b) of the previous subsection show that in the case of both of the afore-
mentioned indications, the dose data includes high-value outliers that pull the mean
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value upwards. Therefore, the median can be seen as a more appropriate point of
reference and thus, also the data of the afore-mentioned indications can be seen as
having suitable characteristics for the establishment of DRLs.
The suggestion of using the 75th percentile is based on the assumption that the
patient dose distributions are skewed with a tail to the right, i.e. towards high dose
values [24, p. 11]. When examining the dose distributions presented in Figures
5.2 and 5.3 in histogram form (not shown), a tail to the right is seen for all of the
seven indications (including the subindications), except for the indication ”Locali-
sation of unerupted and supernumerary teeth (excluding wisdom teeth) (children)”.
The missing tail in the case of the foregoing indication could already be anticipated
based on the descriptive statistics provided in Table 5.2, which show that the mean
and median of the dose distribution are nearly the same for the indication in ques-
tion. Thus, the use of the 75th percentile is not optimal in this case. However, it
would be important to establish a DRL or some other benchmark for the indica-
tion ”Localisation of unerupted and supernumerary teeth (excluding wisdom teeth)
(children)” because the indication concerns children and children are especially ra-
diosensitive [24, p. 8]. Moreover, the foregoing indication was found to be among the
most common indications in Finland in terms of examination frequency. Therefore,
a DRL proposal was given for the afore-mentioned indication despite the shape of
the dose distribution.
As discussed previously, information and data on DRLs for CBCT examinations is
scarce but the SEDENTEXCT consortium has issued an AD of 250 mGy·cm2 for the
placement of a single-tooth implant in adults [102, p. 93]. In the study at hand, a
DRL of 360 mGy·cm2 is proposed for the indication ”Presurgical imaging of implant
treatments: a) imaging of areas with a single missing tooth”. The proposed DRL is
thus approximately 1.4 times the AD. The AD was determined employing the 75th
percentile but it was derived from data normalised to a small FOV size [35, p. 10],
whereas no normalisation was conducted in this study. Therefore, it was expected
that the DRL for single-tooth implant treatments would exceed the AD. The AD
was stated to correspond to the 33rd percentile of the non-normalised data [35,
p. 11]. Calculated from the data used for this study, the 33rd percentile of the
dose distribution for the indication ”Presurgical imaging of implant treatments: a)
imaging of areas with a single missing tooth” is 210 mGy·cm2, i.e. lower than the
AD.
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In addition to the indication ”Presurgical imaging of implant treatments: a) imaging
of areas with a single missing tooth”, the indications ”Assessment of the relationship
between a wisdom tooth and the mandibular canal” as well as ”Assessment of the
periapical region and the root canal morphology of the tooth” essentially pertain
to imaging of a single tooth. Thus, the FOV sizes used in the examinations should
be approximately the same for all the foregoing indications. However, it is seen in
Table 5.3 that the DRL proposal for the indication concerning the periapical region
and root canal is significantly higher than those for the other of the afore-mentioned
indications. This finding highlights the importance of determining DRLs based on
the indication and not on the FOV size, for example. The requirements on image
quality and resolution for the imaging of the periapical region and the root canal
are different from those regarding examinations for the other two indications, which
results in the observed considerable difference in dose.
5.3 Further Analyses on Dose
The patient dose data was further analysed to see the effect of optimisation on
dose. Moreover, it was studied, whether CBCT units of a particular manufacturer
or model produce doses differing significantly from those produced by devices of
other manufacturers or models. The following two subsections present the results of
the foregoing analyses.
5.3.1 Effect of Optimisation on Dose
The respondents were enquired, whether they had used optimised imaging param-
eters and settings or employed the factory default settings of their device. As dis-
cussed in 4.2.5, the answers regarding optimisation were divided into three cate-
gories: 1) optimisation was conducted, 2) factory settings were used or 3) the type
of the employed settings was undefinable based on the answers. Figures 5.4 and
5.5 show the effect of the foregoing categories on dose. The analysis of the effect of
optimisation was conducted for the same data presented in the previous section. In
the bar charts of Figures 5.4 and 5.5, each bar corresponds to a single corrected
dose value and the bars are arranged in ascending order. The colours of the bars
represent the afore-described categories concerning optimisation.
Figures 5.4 and 5.5 show that the dose values of the respondents who reported
having conducted optimisation are found at both ends as well as in the middle
5.3. Further Analyses on Dose 65
0 10 20 30
0
100
200
300
400
500
600
700
D
A
P
(m
G
y
·
cm
2
)
Optimised
Factory Settings
Undefined
(a) Presurgical imaging of implant treatments:
imaging of areas with a single missing tooth
0 10 20
0
200
400
600
800
1000
1200
1400
D
A
P
(m
G
y
·
cm
2
)
Optimised
Factory Settings
Undefined
(b) Presurgical imaging of implant treat-
ments: imaging of the maxilla or mandible
0 10 20 30
0
200
400
600
800
1000
1200
1400
D
A
P
(m
G
y
·
cm
2
)
Optimised
Factory Settings
Undefined
(c) Assessment of the relationship between a
wisdom tooth and the mandibular canal
0 5 10 15 20 25
0
200
400
600
800
1000
1200
1400
D
A
P
(m
G
y
·
cm
2
)
Optimised
Factory Settings
Undefined
(d) Jaw cysts and tumours
Figure 5.4 Effect of optimisation on dose, part 1. Each bar represents a single corrected
dose value. The colour of the bar denotes different categories regarding the optimisation
of the imaging parameters and settings. On the horizontal axis, the bars are arranged in
ascending order according to the dose value.
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Figure 5.5 Effect of optimisation on dose, part 2. Each bar represents a single corrected
dose value. The colour of the bar denotes different categories regarding the optimisation
of the imaging parameters and settings. On the horizontal axis, the bars are arranged in
ascending order according to the dose value.
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parts of the distributions formed by the ordered dose values. However, there are
also indications where none of the very lowest doses resulted from optimisation
and the highest dose was obtained with parameters and settings reported as being
optimised. This is the case for the indications ”jaw cysts and tumours” and ”obscure
pain conditions”. It is also seen in Figures 5.4 and 5.5 that many of the respondent
facilities did not perform optimisation but relied on factory default settings.
Based on Figures 5.4 and 5.5, it can be concluded that the use of optimised imag-
ing parameters and settings does not seem to have resulted in a generalised dose
reduction compared to the use of factory default settings. However, at the level of
individual places of use, the effect of optimisation on dose cannot be deduced from
the results since it is not known what the doses would have been without optimi-
sation. The finding that optimisation did not appear to have lead to a generalised
dose reduction can be seen as illustrating the fact that optimisation is a weighing
process between numerous factors and dose is only one of the factors [43, p. 14], as
discussed previously in conjunction with the principle of optimisation (in Subsec-
tion 3.1.2 General Principles). On the other hand, the principle of optimisation also
includes the requirement to comply with the ALARA principle [45, p. 33]. Thus,
despite optimisation being a weighing process between several aspects, the ALARA
principle imposes restrictions on the outcome of the process with respect to dose.
Therefore, it is highly questionable, whether optimisation has been conducted ade-
quately in those cases where the dose is very high and the place of use claims that
optimised settings were employed.
Overall, when examining all completed questionnaires and all of the indications
included in the survey, 51% of the respondent facilities had used optimised settings in
association with at least one indication or reported that optimisation was conducted
sometimes. The foregoing percentage also includes places of use, where optimised
settings were only used in conjunction with a minority of the indications pertaining
to the place of use in question. The afore-mentioned percentage of facilities that
have conducted optimisation to some extent is modest, considering that the principle
of optimisation is laid down in legislation [19,78] and that the ICRP has specifically
emphasised the role of optimisation in radiological protection [43, p. 13; 46, pp. 14,
44].
As demonstrated by Figures 5.4 and 5.5 and as can be inferred from the afore-
mentioned relatively low percentage of the respondent facilities that had conducted
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optimisation, the use of the pre-defined settings and programmes of the CBCT
devices is prevalent. When discussing the afore-mentioned settings and programmes
with representatives of some manufacturers, the resulting image quality arose as the
major determinant underlying the choice of parameters of the pre-set programmes.
Image quality serving as the principal determinant could lead to the resulting images
being ’too good’ in the sense that poorer image quality would suffice for diagnosis.
’Too good’ images are problematic because the parameters that affect image quality,
such as tube current, also influence the dose [67] and consequently, the patient may
be exposed to unnecessarily high doses. The foregoing assumption of ’too good’
image quality is also supported by studies, which have found that, for example, the
tube currents of pre-set protocols can be lowered significantly without rendering the
resulting image non-diagnostic [18,68]. Against this background, the factory default
settings performed surprisingly well with respect to dose in the indications explored
above. In effect, in the case of six out of the eight indications and subindications
explored, the lowest dose was attained by using factory default settings.
Even though many of the respondents have employed factory default settings di-
rectly, that is not the way the settings are intended to be used based on the user
manuals of some manufacturers. The user manuals include remarks, such as that
the lowest dose that produces sufficient diagnostic image quality should always be
used [39, p. 4; 103, p. 4; 104, p. 2] or that the pre-defined protocols are provided
for guidance purposes only and the users should form their own imaging protocols
[74, p. 1; 75, p. 1; 76, p. 1].
5.3.2 Effect of Manufacturer and Model on Dose
In addition to the effect of optimisation on dose, it was studied whether CBCT
devices of a particular manufacturer or a model produce higher or lower doses than
others. The analysis was conducted in an indication-specific manner for the same
seven indications studied in the previous sections of the chapter. The results for all
of the indications were similar and thus, data is only shown for one of the indications.
Figure 5.6 presents the results pertaining to the indication ”Presurgical imaging of
implant treatments: a) imaging of areas with a single missing tooth”. Similar to
the previous section, each bar in the graph corresponds to a single corrected dose
value. On the horizontal axis, the columns or doses are grouped according to the
manufacturer. Each group, i.e. each manufacturer, is displayed in a different colour.
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Within each group, the columns, i.e. the dose values, are arranged in ascending
order. The vertical texts above the bars denote the different models of the devices.
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Figure 5.6 Effect of manufacturer and model on dose. The data presented is for the
indication ”Presurgical imaging of implant treatments: a) imaging of areas with a single
missing tooth” Each bar represents a single corrected dose value. On the horizontal axis,
the dose values are grouped according to the manufacturers of the CBCT devices. Each
manufacturer is indicated by a different colour of the bar. Within each group, the bars
are arranged in ascending order according to the dose value. The vertical texts above the
bars refer to the different scanner models of the manufacturers. Some of the model names
are not given in full: the models of Planmeca refer to those of the ProMax series and the
models of Sirona to those of the Orthophos series.
Figure 5.6 shows that the doses produced by the CBCT units of the most popular
manufacturers, Planmeca and Soredex, cover a wide range. For both manufacturers,
there are doses among the lowest observed but also the highest doses are produced
by the devices of the foregoing manufacturers. The same applies to the most pop-
ular scanner models of the afore-mentioned manufacturers. For example, for the
indication depicted in Figure 5.6, the highest dose among those for Planmeca was
obtained using the model ProMax Mid. However, also the lowest dose for Planmeca
was generated by the same model. Similarly, in the case of Soredex, the doses for
Scanora 3D comprise the highest dose among those of Soredex but also the fourth
lowest dose as well as doses between the afore-mentioned extremes. Due to the small
5.4. Qualifications 70
number of doses for the remaining three manufacturers, it is hard to appropriately
assess the effect of manufacturer or model on dose for Instrumentarium Dental,
Kodak or Sirona. However, it can be concluded that none of the scanners of the
afore-mentioned manufacturers stood out as producing doses that would have been
out of line compared to the other manufacturers in any of the seven indications
studied.
The above-discussed result that devices of the same manufacturer and even the
same scanner models were found to produce a wide range of doses, suggests that the
observed variation in dose values results mainly from the actions of the users, i.e.
how the device is used, rather than from the device itself. The foregoing conclusion
is reinforced when comparing the imaging parameters and settings employed by
the users who had obtained the highest and lowest doses with the same scanner
model. For example, in the case of the users of the model ProMax Mid for the
indication presented in Figure 5.6, the user with the highest dose had used high-
definition (HD) resolution, whereas the one with the lowest dose had used normal
resolution combined with a ultra-low-dose imaging protocol. The foregoing thus
again accentuates the importance of the optimisation of protocols employed.
It has to be noted, though, that analysing the effect of the scanner model is not
as straightforward as presented here since scanners of different production years
can incorporate different versions of software, for example, and also afterwards the
software can be updated and other modifications, such as fitting of new sensors, can
be made. Therefore, the devices being of the same model does not necessarily mean
that the devices are similar in all respects. Thus, to conduct a more comprehensive
analysis on the effect of scanner models on dose, the software versions and other
characteristics specific to individual devices as well as all the modifications made
afterwards should be taken into account.
5.4 Qualifications
As described previously, STUK has imposed special requirements on the qualifica-
tions of the people responsible for CBCT examinations as well as of the personnel
conducting the examinations [93]. For analysis, the qualifications of the people-in-
charge and the personnel performing the examinations were arranged in categories
based on the assumed radiological knowledge and the frequency of the categories
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was studied, as explained in 4.2.7 Qualifications. The frequency refers to the num-
ber of times the category was mentioned in the completed questionnaires. For each
place of use, each category was counted only once, regardless of the actual number
of people representing the category. The frequencies of the categories are illustrated
in Figure 5.7 regarding both the people responsible for the examinations and the
personnel performing the imaging.
Figure 5.7 shows that the frequencies of the two categories concerning the qualifi-
cations of the people-in-charge are close to each other with the category comprising
specialists in radiology or oral radiology being slightly more common. Regarding
the qualifications of the personnel performing examinations, it is observed that all
of the eligible categories are represented. The category formed by radiographers is
the most common, whereas the category consisting of specialists in radiology or oral
radiology is infrequent.
Regarding five of the respondent facilities, the qualifications of the people responsi-
ble for the examinations were not provided in the survey responses or were reported
unclearly. In the case of two places of use, the dentist-in-charge lacked the re-
quired supplementary training in CBCT imaging. The information pertaining to
the qualifications of the personnel performing the examinations was incomplete in
the responses from two places of use. At five places of use, CBCT imaging was con-
ducted without the requested supplementary training concerning CBCT imaging.
At four of the afore-mentioned five facilities, all members of the personnel con-
ducting CBCT examinations lacked the supplementary training. However, based
on the information received from the respondents, most of those who did not have
the requested qualifications were on the supplementary training course at the time
the survey was conducted or were planning to complete the supplementary training
when next possible. At the remaining place of use, one member of the personnel had
not completed the supplementary training, whereas the rest of the personnel had the
required qualifications. An important finding of the study is thus that some dentists-
in-charge as well as some members of the personnel performing CBCT examinations
lack the required supplementary training even though the transition period given
for completing the afore-mentioned training ended already over three years ago [93].
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Figure 5.7 Qualifications of the people-in-charge for CBCT examinations and of those
performing the examinations. The foregoing qualifications are arranged in categories, the
frequencies of which are shown in the bar graphs. The categories are presented in ab-
breviated form. The abbreviated forms refer to the following categories: in a) specialists:
radiology = specialists in radiology or oral radiology; others = dentists (licentiates of den-
tistry), physicians (licentiates of medicine), medical and dental specialists with a speciality
other than radiology or oral radiology and in b) dentists/physicians = physicians (licenti-
ates of medicine), medical and dental specialists with a speciality other than radiology or
oral radiology; specialists: radiology = specialists in radiology or oral radiology.
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6. CONCLUSIONS
The main objective of the study was to collect national patient dose data for the
establishment of indication-based DRLs for CBCT examinations of the head and
neck region in Finland and based on the data, to form proposals for the prospective
DRLs. Concomitant with the primary objective, the study was to determine the
indications for which CBCT examinations are conducted in Finland and indication-
specific examination frequencies. Furthermore, the study aimed to investigate the
qualifications of the people in charge of the CBCT examinations as well as those of
the personnel performing the examinations, and whether the qualifications complied
with the requirements imposed by STUK. Additionally, the study explored the use
of optimised imaging parameters and the effect thereof on dose. Dose was also
analysed with respect to the manufacturer and model of the CBCT device used.
The study was conducted as a survey among Finnish facilities performing CBCT ex-
aminations of the head and neck. The survey employed a self-designed questionnaire
with a pre-defined list of indications for CBCT examinations. The respondents were
asked to report dose readings in an indication-based manner assuming the patient
was an average-sized male and for the indications pertaining to children, assuming
the patient was typical of the indication. Additionally, information on the CBCT
unit, imaging parameters and settings, the use of optimised settings as well as es-
timated examination frequencies were requested. Completed questionnaires were
received from 43 places of use and for 47 CBCT devices, the response rate being
57%, in terms of listed places of use and 56%, in terms of registered devices. The
reported dose readings were corrected for dose display error and the corrected data
was used in the analyses. The proposals for the DRLs were derived from the 75th
percentile values of the indication-specific patient dose distributions. The 75th per-
centiles were determined using a built-in function of MATLAB R2015b that employs
linear interpolation in computing the percentiles.
The results of the study show that CBCT imaging is applied to a wide variety of
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indications in Finland. Despite a wide spectrum, only nine of the indications cov-
ered 93% of all CBCT examinations of the head and neck. The nine most common
indications included one indication concerning only children. In terms of examina-
tion frequency, the most important indications for CBCT examinations in Finland
fell into the following categories (starting from the most common): 1) presurgical
imaging of implant treatments, 2) the assessment of the relationship between a wis-
dom tooth and the mandibular canal, 3) inflammatory changes, polyps and tumours
of the paranasal sinuses and the nasal meatus and 4) assessment of the periapical
region and the root canal morphology of the tooth. The afore-mentioned most im-
portant indications are in accordance with those found in the recommendations on
the clinical use of CBCT [20,26]. Thus, indication-wise, CBCT appears to be applied
appropriately in Finland. The results are also concordant with literature reporting
that the imaging of sinuses has emerged as a common indication alongside the more
traditional dental indications [15,30,106].
The sum of the estimated monthly examination frequencies reported by the respon-
dents translated into a total number of approximately 20 000 CBCT examinations
per year. The afore-mentioned annual total is, however, significantly higher than
suggested by the preliminary results of another survey conducted by STUK [82] that
pertained to the same target group and year as the study at hand. The substan-
tial difference in the results of the two studies may indicate that the examination
frequencies provided by the respondents of this study are overestimated. Based on
the results of the two studies, it can, however, be concluded that the total annual
number of CBCT examinations of the head and neck is over 10 000 in Finland.
The number of examinations is of such magnitude that CBCT can be regarded as
a common examination type and hence, there are grounds for the establishment of
DRLs.
The number of data points was sufficient for a closer analysis of the dose distributions
in the case of seven indications, one of which consisted of two subindications. One
of the afore-mentioned indications pertained to children, whereas all the others were
indications for adult examinations. In all of the analysed cases, the indication-
specific patient dose range was extensive, with minimum-to-maximum dose ratios
ranging from 7 to 50. With few exceptions, the data for each indication consisted
of one dose value or data point per place of use. Thus, the foregoing results also
indicate that the differences in patient dose are substantial between the places of
use across Finland. In terms of patient safety, such differences in dose should not
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exist. The existence of such large differences shows that there is a serious need for
DRLs for CBCT examinations in Finland.
DRL proposals were made for all of the afore-mentioned seven indications, including
individual proposals for the subindications. All of the DRL proposals for adult ex-
aminations can be considered compliant with the guidelines of the EC and ICRP on
DRLs with respect to the quality of the dose data and the statistical characteristics
of the dose distributions. The shape of the distribution of the indication pertaining
to children was not optimal for the use of the 75th percentile approach. A DRL
proposal was, nevertheless, formed for the afore-mentioned indication since children
are especially sensitive to radiation [24, p. 8] and thus, it is important to provide at
least some kind of a benchmark for the indication in question.
The most important finding regarding the qualifications was that there were several
places of use, where CBCT imaging was conducted with qualifications not meeting
the requirements issued by STUK. Furthermore, in the case of two places of use,
the dentist-in-charge lacked the supplementary training on CBCT that is required
for the dentists responsible for CBCT examinations.
The exploration of the use of optimised imaging parameters and settings revealed
that only 51% of the respondents had used optimised settings or at least conducted
optimisation sometimes, if not in conjunction with all indications or examinations.
For some of the respondents, the type of the employed settings could not be defined
based on the answers. The rest had used the default factory settings of their CBCT
units. The portion of the respondents who had used optimised settings is strikingly
low, considering that the principle of optimisation is laid down in the ST Guides of
STUK, in the Finnish and European legislation as well as in the international rec-
ommendations of the ICRP [19,46,78, 94, 111]. Moreover, despite providing default
programmes and settings, also manufacturers state in the user’s manuals that the
purpose of the default settings is only advisory and that the lowest dose producing
sufficient image quality should be strived for [39, 74–76, 103, 104]. The use of opti-
mised settings did not, however, appear to result in a generalised dose reduction, and
many of the lowest values were actually obtained by using factory default settings.
The foregoing can be seen as demonstrating that dose is not the only component
in the process of optimisation, but potentially also as an indicator of inadequate
optimisation. When examining dose as a function of the device used, the observed
large variations in dose could not be attributed to any single manufacturer or de-
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vice model. Rather, even the same models of the same manufacturer were found to
produce a wide range of doses within the same indications, suggesting that the dose
variations mainly result from the actions of the user.
The study and its results are an important contributor to radiation safety in Finland.
First and foremost, the study provides STUK with patient dose data and proposals
for indication-based DRLs, which enable the establishment of the Finnish DRLs
for CBCT examinations. The DRLs for CBCT examinations are already being
prepared by STUK based on the study and will be issued in the near future. The
establishment and the application of the DRLs is expected to modify the Finnish
patient dose distributions by removing the highest dose values observed in this study.
DRLs are revised at intervals of some years. In conjunction with the revision of the
prospective DRLs, the realised effect of the DRLs can be assessed by using the
results of the study at hand as a reference. Moreover, the questionnaire developed
for the study and the methods used in analysing the data can be utilised in future
dose studies concerning CBCT examinations.
In addition to providing data and proposals for the establishment of DRLs, the
study gives essential information on the radiation practices regarding CBCT exami-
nations in Finland. The results of the study showed that a significant portion of the
respondents had not optimised the imaging parameters but had directly used the
factory default settings of the devices, which is against the principle of optimisation.
Furthermore, the study revealed infringements of the requirements of STUK for the
qualifications of the people in charge of and performing CBCT examinations. The
afore-mentioned results are a signal that the matters of optimisation and required
qualifications should be looked into more closely in the future. A possibility for ad-
dressing the former issue would be to enquire about the optimisation of the imaging
settings as a part of the inspections conducted by STUK at the places of use. The
current inspection practices already include checking the qualifications, which raises
the question how it is possible that several instances of lacking qualifications were
found. However, it is likely that the places of use in question had not been inspected
after the introduction of the current qualification requirements. Moreover, the per-
sonnel performing the examinations may change between the inspections. Therefore,
the introduction of a system for checking the qualifications regularly between the
inspections should be considered by STUK.
The study can also be considered pioneering in an international perspective in the
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sense that Finland is one of the first, if not the first, country to issue DRLs for
CBCT examinations. The ICRP stated in its publication devoted to CBCT in 2015
that little progress has been made towards the establishment of DRLs for CBCT
and that the literature on DRLs for CBCT is scarce [98, p. 100]. The study is thus
of significant importance in providing new information to the field.
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APPENDIX A. QUESTIONNAIRE
CBCT Examinations of the Head and Neck Region
Indications
Estimated 
number of 
examinations 
per month
Tube voltage 
(kV)
Tube current 
(mA)
Voxel size 
(mm) or 
resolution 
setting
Field of 
view (FOV) 
size
(Ø x H), cm
Scanning/
exposure 
time (s) 
Patient size 
setting 
Name of the 
imaging 
programme of 
the device
Were factory default 
settings or optimised 
imaging settings 
used? 
(F = factory settings/
O = optimised)
Dose display 
DAP (mGy cm
2
)
Error of the 
dose display 
(%, direction 
+/-)
Presurgical imaging of implant treatments
a) imaging of areas with a single missing tooth
b) imaging of the maxilla or mandible
Assessment of the relationship between a wisdom tooth and 
the mandibular canal
Jaw cysts and tumours
Tooth fractures
Alveolar fractures
Jaw or condylar fractures
Dysfunction of the masticatory system (TMJ area)
Orthognathic surgery
Localisation of unerupted and supernumerary teeth 
(excluding wisdom teeth) (children)
Cleft palate (children)
3-dimensional cephalometry
3-dimensional cephalometry (children)
Airway assessment
Obscure pain conditions
Assessment of the periapical region and the root canal 
morphology of the tooth
Periodontal diseases
Inflammatory changes, polyps and tumours of the paranasal 
sinuses and the nasal meatus
Trauma of the paranasal sinuses (including orbital floor)
Fractures of the cervical spine
Spondyloarthropathy of the cervical spine
Anomalies and changes of the outer auditory canal as well as 
of the inner and middle ear
Otomastoiditis
Assessment of inner or middle ear implant positioning
3D modelling
Computer-aided surgical planning
Manufacturing of customised implants
Device (manufacturer and model): 
Place of use:
Safety licence number:
Imaging Settings DoseImaging Parameters
Qualifications of the personnel performing the examinations:
Qualifications of the dentist/physician responsible for the examinations:
Filtration of the device (Al/Cu and thickness):
92
APPENDIX B. COVER LETTER
                                               COVER LETTER 1(3) 
  
  
 6th May 2015 
STUK • SÄTEILYTURVAKESKUS Osoite • Laippatie 4, 00880 Helsinki 
STRÅLSÄKERHETSCENTRALEN Postiosoite • PL 14, FIN-00881 Helsinki 
RADIATION AND NUCLEAR SAFETY AUTHORITY Puh. (09) 759 881 • Telekopio (09) 759 88 248 • www.stuk.fi 
 
 
 
 
 
Translation of the original cover letter (in Finnish) with contact details omitted. 
 
 
Dose survey: diagnostic reference levels in cone-beam computed tomography examinations of 
the head and neck region  
 
The Decree of the Ministry of Social Affairs and Health on the medical use of radi-
ation (423/2000; 2 §, 16 § and 17 §) obliges the parties running a radiation practice 
to apply diagnostic reference levels (DRLs) to X-ray examinations. The decree also 
stipulates that the DRLs for the most common examinations are established by the 
Radiation and Nuclear Safety Authority (STUK). 
 
STUK is establishing DRLs for cone-beam computed tomography (CBCT) exami-
nations of the head and neck region. The aim of the present dose survey is to de-
termine indication-based DRLs. In addition, indication-specific examination fre-
quencies, the use of default imaging settings of the devices as well as the qualifica-
tions of the dentists/physicians responsible for the CBCT examinations and those 
of the personnel conducting the examinations are studied.  
 
For the establishment of the DRLs, we ask you to complete the attached Excel table 
in a device-specific manner according to the instructions given below. 
 
General 
 
The Excel table consists of a single sheet (Head and Neck CBCT), in which infor-
mation pertaining to a single device and to the examinations conducted using the 
device in question shall be filled in. The information shall be entered in an indica-
tion-specific manner using the pre-defined list of indications provided in the table. 
The information shall be given assuming the patient was an average-sized male 
with the exception of the indications followed by the text ”children” in red and in 
parentheses. For the latter indications, please enter the information assuming the 
patient being examined represents a patient typical of the indication in question. 
We also ask you to mark the age of the typical patient after the text “children” in 
the column Indications.  
 
In the box at the top of the sheet, please fill in the safety licence number and the 
place of use of the device as well as the following information regarding the de-
vice: manufacturer, model and filtration (if known). Regarding the filtration, the 
material and the thickness of the filter shall be given. Additionally, qualifications of 
the dentists/physicians responsible for the examinations and those of the personnel 
performing the examinations shall be entered. The qualifications refer to the quali-
fication requirements laid down in ST-Guide 3.1 (13.6.2014; item 3.2).  
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Please submit the completed form by e-mail to ****.****@****.fi by 22th May 
2015 at the latest. 
 
Questions concerning the survey can be addressed to Sonja Turnbull-Smith, ****-
******, ****.****@****.fi and Atte Lajunen, **-********,  
****.****@****.fi 
 
Additional instructions on completing the form are given below. 
 
 Indications 
 
The column Indications contains a pre-filled list of indications for the CBCT exam-
inations of the head and neck region. Each indication has its own row. The indica-
tions are divided into five groups: 1) dentition and jaw area 2) paranasal sinuses 3) 
cervical spine area 4) temporal bone and 5) others. The grouping is indicated by 
colour coding in the table. We ask you to complete the information with respect to 
the indications concerning your place of use. The rows concerning other indications 
shall be left blank.  
 
 Estimated Number of Examinations 
 
In the column Estimated number of examinations per month, we ask you to esti-
mate the number of examinations conducted per month for each indication.  
 
Imaging Parameters 
 
In the section Imaging Parameters, the tube voltage and current, the size of the field 
of view (FOV) as well as the scanning or exposure time employed in the examina-
tion shall be completed in the unit given in parentheses. The FOV size shall be giv-
en in the form of diameter x FOV height. Additionally, the voxel size in millime-
tres or the resolution setting of the device used in the examination shall be given.  
 
Imaging Settings 
 
In the section Imaging Settings, the selected patient size and the name of the imag-
ing programme used shall be given. The imaging programme of the device refers to 
pre-set imaging programmes or imaging protocols that are found in some CBCT 
devices and that provide pre-defined imaging parameters (e.g. tube current and 
voltage). In addition, information is requested on, whether the factory default set-
tings of the afore-mentioned imaging programmes/protocols were used directly or 
whether the imaging parameters were optimised. If factory default settings were 
used directly, please enter the letter ‘F’ in the column “Were factory default set-
tings or optimised imaging settings used?”. If optimised parameters were used, 
shall the letter ‘O’ be entered in the afore-mentioned column. The information ob-
tained through the question is used to study the prevalence of the use of optimised 
settings.   
  
 Dose 
 
In the column Dose display DAP, the DAP dose reading given by the dose display 
of the device shall be filled in. In the column Error of the dose display, please enter 
the percent error of the dose display according to maintenance documentation or 
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measurements by STUK. In conjunction with the percent error, the direction of the 
error shall also be given (e.g. +10 %). A positive sign implies that the reading of 
the dose display is higher than the true dose. A negative sign shall be used if the 
reading of the dose display is lower than the true dose. The error of the dose dis-
play should be determined using the same tube voltage and FOV size as used in the 
examination, for which the DAP dose reading of the dose display has been given. 
 
 Thank you very much for your co-operation already in advance! 
